US20020007520A1 - Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles - Google Patents

Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles Download PDF

Info

Publication number
US20020007520A1
US20020007520A1 US09/212,578 US21257898A US2002007520A1 US 20020007520 A1 US20020007520 A1 US 20020007520A1 US 21257898 A US21257898 A US 21257898A US 2002007520 A1 US2002007520 A1 US 2002007520A1
Authority
US
United States
Prior art keywords
amino
triazole
radical
pyrazolo
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/212,578
Other versions
US6379397B2 (en
Inventor
Laurent Vidal
Mireille Maubru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Assigned to L'OREAL S.A. reassignment L'OREAL S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MAUBRU, MIREILLE, VIDAL, LAURENT
Publication of US20020007520A1 publication Critical patent/US20020007520A1/en
Priority to US10/091,492 priority Critical patent/US6855827B2/en
Application granted granted Critical
Publication of US6379397B2 publication Critical patent/US6379397B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A composition for dyeing keratinous fibers, in particular human keratinous fibers, such as human hair, containing, in a medium suitable for dyeing:
as oxidation base, at least one compound of formula (I) below:
Figure US20020007520A1-20020124-C00001
in which:
R1 is a hydrogen atom, an alkyl radical, an aryl radical, a heterocycle radical, or a halogen atom,
R2 is a hydrogen atom, an alkyl radical, a hydroxyalkyl radical, or an aminoalkyl radical,
Za, Zb and Zc are independently a nitrogen atom or a carbon carrying an R3 or R4 radical with meanings identical to those of R1; wherein at least one of Za, Zb and Zc is a nitrogen atom; it being possible for R3 and R4 to form between themselves a substituted or unsubstituted aromatic ring.

Description

  • The invention relates to a composition for the oxidation dyeing of keratinous fibers, and in particular of human keratinous fibers such as human hair, comprising at least one pyrazoloazole compound as an oxidation base, the method of dyeing which employs this composition, and novel pyrazoloazoles. [0001]
  • It is well known to dye keratinous fibers, and in particular human hair, using dyeing compositions comprising oxidation dye precursors, such as ortho- or para-phenylenediamines, ortho- or para-aminophenols, and heterocyclic compounds, which are generally referred to as oxidation bases. The oxidation dye precursors, or oxidation bases, are colorless or lightly colored compounds which, when combined with oxidizing products, can give rise, by an oxidative coupling process, to colored and coloring compounds. [0002]
  • It is also known that the shades obtained with these oxidation bases can be varied by combining them with couplers or coloring modifiers, the latter being chosen in particular from aromatic meta-diamines, meta-aminophenols, meta-diphenols and certain heterocyclic compounds, such as indole compounds. [0003]
  • The diversity of the molecules employed as oxidation bases and couplers makes it possible to obtain a wide range of colors. [0004]
  • The “permanent” coloration obtained by these oxidation dyes should optimally meet certain conditions. Thus, it should have no toxicological effects, should allow shades of the desired intensity to be obtained, and should have good resistance to external agents (light, bad weather, washing, permanent waving, perspiration or rubbing). [0005]
  • The dyes should also allow white hairs to be covered and, finally, they should be as unselective as possible, that is to say, they should allow the smallest possible differences in coloration to be produced over the entire length of a single keratinous fibre, which may vary in condition of sensitization or damage from its tip to its root. They should also exhibit good chemical stability in the formulations and a good toxicological profile. [0006]
  • The inventors have discovered that it is possible to obtain powerful novel dyes which are not very selective, are particularly resistant to various external agents which keratinous fibers can be subjected to, and which are capable of generating intense colorings in varied shades by using, as oxidation base, pyrazoloazole compounds of formula (I) defined below. [0007]
  • This discovery is the basis of the present invention. [0008]
  • The first aspect of the invention is thus a composition for the oxidation dyeing of keratinous fibers, and in particular human keratinous fibers such as hair, comprising, in a medium suitable for dyeing: [0009]
  • as oxidation base, at least one pyrazoloazole compound of formula (I) or at least one acid addition salt thereof: [0010]
    Figure US20020007520A1-20020124-C00002
  • in which: [0011]
  • R[0012] 1 represents: a hydrogen atom; a linear or branched C1-C20 alkyl radical, optionally substituted by 1 or 2 radicals R chosen from a halogen atom, a nitro radical, a cyano radical, a hydroxyl radical, an alkoxy radical, an aryloxy radical, an amino radical, an alkylamino radical, an acylamino radical, a carbamoyl radical, a sulphonamido radical, a sulphamoyl radical, an imido radical, an alkylthio radical, an arylthio radical, an aryl radical, such as phenyl or naphthyl, a (C1-C4)alkoxy-carbonyl radical and an acyl radical; an aryl radical (such as phenyl or naphthyl), optionally substituted by 1 or 2 radicals R as defined above; a 5- or 6-membered heterocycle containing at least one nitrogen, oxygen or sulphur atom (such as pyridyl, quinolyl, pyrrolyl, morpholyl, furanyl, tetrahydrofuranyl, pyrazolyl, triazolyl, tetrazolyl, thiazolyl, oxazolyl, imidazolyl or thiadiazolyl), wherein said heterocycle is optionally substituted by 1 or 2 radicals R as defined above;
  • when R[0013] 1 denotes a C1-C4 alkyl radical, an aryl radical or a 5- or 6-membered heterocycle (as defined above), it can be connected to the carbon atom of the pyrazole via an oxygen, nitrogen or sulphur atom (in this case, R1 becomes XR1 with X=O, NH or S);
  • R[0014] 1 can, additionally, denote a halogen atom (such as bromine, chlorine or fluorine); an acyl radical; a sulphonyl radical; a sulphinyl radical; a phosphonyl radical; a carbamoyl radical; a sulphamoyl radical; a cyano radical; a siloxy radical; an amino radical; an acylamino radical; an acyloxy radical; a carbamoyloxy radical; a sulphonamide radical; an imide radical; a ureido radical; a sulphamoylamino radical; a (C1-C4)alkoxy-carbonylamino radical; an aryloxycarbonylamino radical; a (C1-C4)alkoxy-carbonyl radical; an aryloxycarbonyl radical; a carboxyl radical; or a hydroxyl radical;
  • R[0015] 2 denotes a hydrogen atom; a C1-C4 alkyl radical; a C1-C4 monohydroxyalkyl radical; a C2-C4 polyhydroxyalkyl radical; a C1-C4 aminoalkyl radical; a (CH2)p—X—(CH2)qOR′ radical in which p and q are identical or different integers ranging from 1 to 3, R′ represents a hydrogen atom or a methyl radical, and X denotes an oxygen atom or an NR″ group in which R″ represents a hydrogen atom or a methyl radical; a (C1-C4)alkoxy(C2-C4)alkyl radical; or a di(C1-C4)alkylamino(C1-C4)alkyl radical; and
  • Z[0016] a, Zb and Zc represent, independently of one another, a nitrogen atom or a carbon atom carrying an R3 or R4 radical, where R3 and R4 have the same meanings as those indicated above for the R1 radical, with the proviso that at least one of the Za, Zb and Zc radicals is other than a carbon atom; R3 and R4 can also together form a substituted or unsubstituted aromatic ring, such as a phenyl ring.
  • Preferred R[0017] 1 radicals of the compounds of formula (I) defined above are chosen from a hydrogen atom; a linear or branched C1-C4 alkyl radical; a phenyl ring; a phenyl ring substituted by a halogen atom, a C1-C4 alkyl radical, a C1-C4 alkoxy radical, a nitro radical, an amino radical, a trifluoromethyl radical or a C1-C4 alkylamino radical; a benzyl radical; a benzyl radical substituted by a halogen atom, a C1-C4 alkyl radical, a C1-C4 alkoxy radical, a nitro radical, an amino radical, a trifluoromethyl radical or a C1-C4 alkylamino radical; a heterocycle chosen from the thiophene, furan or pyridine rings; a trifluoromethyl radical; a (CH2)p—X—(CH2)q—OR′ radical in which p and q are identical or different integers ranging from 1 to 3, where R′ represents a hydrogen atom or a methyl radical and X denotes an oxygen atom or an NR″ radical in which R″ denotes a hydrogen atom or a methyl radical; a C1-C4 hydroxyalkyl radical; a C1-C4 aminoalkyl radical; a C1-C4 alkylamino radical; a di(C1-C4)alkylamino radical; an arylamino radical; an alkoxy radical chosen from methoxy, ethoxy and phenoxy; a halogen atom chosen from bromine, chlorine and fluorine; a carboxyl group; a C1-C4 alkoxycarbonyl radical; a phenyloxycarbonyl radical; a methylthio radical; an ethylthio radical; a phenylthio radical; a methanesulphonyl radical; a cyano radical; an amino radical; or a hydroxyl radical.
  • More preferred R[0018] 1 radicals of the compounds of formula (I) defined above are chosen from a hydrogen atom; an alkyl radical chosen from the methyl, ethyl, isopropyl and tert-butyl radicals; a halogen atom chosen from chlorine and fluorine; a phenyl radical; a toluyl radical; a 4-chlorophenyl radical; a 4-methoxyphenyl radical; a 3-methoxyphenyl radical; a 2-methoxyphenyl radical; a benzyl radical; a heterocycle chosen from the pyridyl, furyl and thienyl rings; a trifluoromethyl radical, a hydroxymethyl radical; an aminomethyl radical; a methoxy radical; an ethoxy radical; a methylamino radical; an ethylamino radical; a dimethylamino radical; a carboxyl radical; a methoxycarbonyl radical; an ethoxycarbonyl radical and a cyano radical.
  • More particularly preferred R[0019] 1 radicals are chosen from: a hydrogen atom; a chlorine atom; a methyl radical; an ethyl radical; a phenyl radical; a toluyl radical; a 4-chlorophenyl radical; a 4-methoxyphenyl radical; a benzyl radical; a trifluoromethyl radical; a methoxy radical; an ethoxy radical; a carboxyl radical; a methylamino radical; a dimethylamino radical and a cyano radical.
  • Preferred R[0020] 2 radicals of the compounds of formula (I) defined above are chosen from a hydrogen atom; a methyl radical and a β-hydroxyethyl radical.
  • More preferably, the R[0021] 2 radical represents a hydrogen atom.
  • Preferred R[0022] 3 and R4 radicals of the compounds of formula (I) defined above are chosen from a hydrogen atom; a hydroxyl radical; an amino radical; a linear or branched C1-C4 alkyl radical; a trifluoromethyl radical; a phenyl ring; a phenyl ring substituted by one or two radicals R chosen from a halogen atom, a C1-C4 alkyl radical, a C1-C4 alkoxy radical, a hydroxyl radical, a carboxyl radical, a nitro radical, a C1-C4 alkylthio radical, a methylenedioxy radical, an amino radical, a trifluoromethyl radical and a C1-C4 alkylamino radical; a benzyl radical; a benzyl radical substituted by a halogen atom, a methyl or isopropyl radical or a methoxy radical; a C1-C4 monohydroxyalkyl radical; a C1-C4 aminoalkyl radical; a (C1-C4)alkylamino(C1-C4)alkyl radical; an alkoxy radical chosen from the methoxy, ethoxy and phenoxy radicals; a methylthio radical; an ethylthio radical; a phenylthio radical; a methanesulphonyl radical; or a substituted or unsubstituted aromatic ring formed jointly by R3 and R4, such as a phenyl ring, pyridyl ring or phenyl ring substituted by a sulphonyl radical, a halogen atom, a C1-C4 alkoxy radical, a C1-C4 alkyl radical, a nitro radical, a cyano radical, an amino radical, a C1-C4 alkylamino radical or a trifluoromethyl radical.
  • More preferred R[0023] 3 and R4 radicals of the compounds of formula (I) defined above are chosen from a hydrogen atom; an alkyl radical chosen from the methyl, ethyl, isopropyl, n-propyl and tert-butyl radicals; a phenyl ring; a toluyl ring; a 2-, 3- or 4-chlorophenyl ring; a 3- or 4-hydroxyphenyl ring; a 3- or 4-aminophenyl ring; a 3- or 4-methoxyphenyl ring; a 4-trifluoromethylphenyl ring; a benzyl ring; a trifluoromethyl radical; a hydroxymethyl radical; a hydroxyethyl radical; a hydroxyisopropyl radical; an aminomethyl or aminoethyl radical; a methoxy or ethoxy radical; a methylthio or ethylthio radical; or a substituted or unsubstituted aromatic ring formed jointly by R3 and R4, such as a phenyl, toluyl, sulphonylphenyl and chlorophenyl ring.
  • More particularly preferred R[0024] 3 and R4 radicals are chosen from a hydrogen atom; a methyl radical; an ethyl radical; an isopropyl radical; a phenyl ring; a 4-chlorophenyl ring; a 4-methoxyphenyl ring; a 4-aminophenyl ring; a methoxy or ethoxy radical; a methylthio or ethylthio radical and a phenyl ring formed jointly by R3 and R4.
  • Preferred compounds of formula (I) in accordance with the invention, are: [0025]
  • i) the pyrazolo[1,5-b]-1,2,4-triazoles of formula (Ia) and the acid addition salts thereof: [0026]
    Figure US20020007520A1-20020124-C00003
  • ii) the pyrazolo[3,2-c]-1,2,4-triazoles of formula (Ib) and the acid addition salts thereof: [0027]
    Figure US20020007520A1-20020124-C00004
  • iii) the pyrazolotetrazoles of formula (Ic) and the acid addition salts thereof: [0028]
    Figure US20020007520A1-20020124-C00005
  • iv) the pyrazolo[1,5-a]imidazoles of formula (Id) and the acid addition salts: [0029]
    Figure US20020007520A1-20020124-C00006
  • v) the pyrazolo[5,1-e]pyrazoles of formula (Ie) and the acid addition salts: [0030]
    Figure US20020007520A1-20020124-C00007
  • vi) the pyrazolo[5,1-e]-1,2,3-triazoles of formula (If) and the acid addition salts thereof: [0031]
    Figure US20020007520A1-20020124-C00008
  • in which R[0032] 1, R2, R3 and R4 have the same meanings as those indicated above for formula (I).
  • Preferred compounds of formulae (Ia) and (Ib), are those in which: [0033]
  • R[0034] 1 denotes a hydrogen atom or a methyl, trifluoromethyl, carboxyl, phenyl, ethoxy, cyano, ethylthio, amino or hydroxyl radical;
  • R[0035] 2 denotes a hydrogen atom;
  • R[0036] 3 denotes a hydrogen atom or a methyl, β-aminoethyl, ethyl, isopropyl, phenyl, β-hydroxyethyl, methylthio or ethoxy radical.
  • Preferred compounds of formula (Ic), are those in which: [0037]
  • R[0038] 1 denotes a hydrogen atom or a methyl, trifluoromethyl, carboxyl, phenyl, ethoxy or cyano radical;
  • R[0039] 2 denotes a hydrogen atom.
  • Preferred compounds of formula (Id), are those in which: [0040]
  • R[0041] 1 denotes a hydrogen atom or a methyl, trifluoromethyl, carboxyl, phenyl, ethoxy, cyano, amino, ethylthio or hydroxyl radical;
  • R[0042] 2 denotes a hydrogen atom;
  • R[0043] 3 and R4 respectively denote a hydrogen atom and a hydrogen atom, a hydrogen atom and a methyl radical, a methyl radical and a hydrogen atom, a hydrogen atom and a phenyl radical, or a hydroxyl radical and a hydrogen atom; or R3 and R4 jointly form a phenyl ring.
  • Preferred compounds of formula (Ie), are those in which: [0044]
  • R[0045] 1 denotes a hydrogen atom or a methyl, trifluoromethyl, carboxyl, phenyl, ethoxy or cyano radical;
  • R[0046] 2 denotes a hydrogen atom;
  • R[0047] 3 and R4 respectively denote a hydrogen atom and a methyl radical, a methyl radical and a hydrogen atom, a methyl radical and a methyl radical, a hydrogen atom and a phenyl radical, or a hydrogen atom and an amino radical.
  • Preferred compounds of formula (If), are those in which: [0048]
  • R[0049] 1 denotes a hydrogen atom or a methyl, trifluoromethyl, carboxyl, phenyl, ethoxy or cyano radical;
  • R[0050] 2 denotes a hydrogen atom;
  • R[0051] 3 denotes a hydrogen atom or a methyl radical.
  • Preferred compounds of formulae (Ia) which can be used in the dyeing compositions, in accordance with the invention, are: [0052]
  • -7-amino-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0053]
  • -7-amino-2-ethylpyrazolo[1,5-b]-1,2,4-triazole; [0054]
  • -7-amino-2-isopropylpyrazolo[1,2-b]-1,2,4-triazole; [0055]
  • -7-amino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole; [0056]
  • -7-amino-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole; [0057]
  • -7-amino-6-methyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole; [0058]
  • -7-amino-6-methyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0059]
  • -7-amino-6-methyl-2-phenylpyrazolo[1,5-b]-1,2,4-triazole; [0060]
  • -7-amino-6-carboxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0061]
  • -7-amino-6-carboxy-2-ethylpyrazolo[1,5-b]-1,2,4-triazole; [0062]
  • -7-amino-6-carboxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0063]
  • -7-amino-6-carboxy-2-phenylpyrazolo[1,5-b]-1,2,4-triazole; [0064]
  • -7-amino-6-phenyl-2-methylpyrazolo[1,5-1,2,4-triazole; [0065]
  • -7-amino-6-phenyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole; [0066]
  • -7-amino-6-phenyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0067]
  • -6,7-diamino-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0068]
  • -6,7-diamino-2-ethylpyrazolo[1,5-b]-1,2,4-triazole; [0069]
  • -6,7-diamino-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0070]
  • -6,7-diamino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole; [0071]
  • -7-amino-6-ethylthio-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0072]
  • -7-amino-6-ethylthio-2-ethyl pyrazolo[1,5-b]-1,2,4-triazole; [0073]
  • -7-amino-6-ethylthio-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0074]
  • -7-amino-6-ethylthio-2-phenylpyrazolo[1,5-b]-1,2,4-triazole; [0075]
  • -7-amino-6-ethoxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0076]
  • -7-amino-6-ethoxy-2-ethylpyrazolo[1,5-b]-1,2,4-triazole; [0077]
  • -7-amino-6-ethoxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0078]
  • -7-amino-6-ethoxy-2-phenylpyrazolo[1,5-b]-1,2,4-triazole; [0079]
  • -7-amino-6-methyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0080]
  • -7-amino-6-carboxy-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0081]
  • -7-amino-6-phenyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0082]
  • -7-amino-6-ethylthio-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0083]
  • -7-amino-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0084]
  • -7-amino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0085]
  • -7-amino-6-methyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0086]
  • -7-amino-6-ethylthio-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0087]
  • -7-amino-6-carboxy-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0088]
  • -7-amino-6-phenyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0089]
  • -6,7-diamino-2-(2′-aminoethyl)pyrazolo[1,5-]-1,2,4-triazole; [0090]
  • -6,7-diamino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0091]
  • -7-amino-6-ethoxy-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0092]
  • -7-amino-6-ethoxy-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0093]
  • and the acid addition salts thereof. [0094]
  • Preferred compounds of formulae (Ib) which can be used in the dyeing compositions, in accordance with the invention, are: [0095]
  • -7-amino-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0096]
  • -7-amino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0097]
  • -7-amino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0098]
  • -7-amino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0099]
  • -7-amino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0100]
  • -7-amino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0101]
  • -7-amino-6-methyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0102]
  • -7-amino-3,6-dimethylpyrazolo[3,2-c]-1,2,4-triazole; [0103]
  • -7-amino-6-methyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0104]
  • -7-amino-6-methyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0105]
  • -7-amino-6-methyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0106]
  • -7-amino-6-methyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0107]
  • -7-amino-6-methyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole; [0108]
  • -7-amino-6-phenyl-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0109]
  • -7-amino-6-phenyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0110]
  • -7-amino-6-phenyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0111]
  • -7-amino-6-phenyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0112]
  • -7-amino-6-phenyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0113]
  • -7-amino-6-phenyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0114]
  • -7-amino-6-phenyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole; [0115]
  • -7-amino-6-ethylthio-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0116]
  • -7-amino-6-ethylthio-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0117]
  • -7-amino-6-ethylthio-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0118]
  • -7-amino-6-ethylthio-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0119]
  • -7-amino-6-ethylthio-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0120]
  • -7-amino-6-ethylthio-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0121]
  • -7-amino-6-trifluoromethyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole; [0122]
  • -7-amino-6-(trifluoromethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0123]
  • -7-amino-6-carboxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0124]
  • -7-amino-6-carboxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0125]
  • -7-amino-6-carboxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0126]
  • -7-amino-6-carboxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0127]
  • -7-amino-6-carboxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0128]
  • -7-amino-6-carboxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0129]
  • -6,7-diamino-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0130]
  • -6,7-diamino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0131]
  • -6,7-diamino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0132]
  • -6,7-diamino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0133]
  • -7-amino-6-ethoxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0134]
  • -7-amino-6-ethoxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0135]
  • -7-amino-6-ethoxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0136]
  • -7-amino-6-ethoxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0137]
  • -7-amino-6-ethoxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0138]
  • -7-amino-6-ethoxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0139]
  • -6,7-diamino-3-(2′-aminoethyl)pyrazolo[3,2-c]-,2,4-triazole; [0140]
  • -6,7-diamino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0141]
  • and the acid addition salts thereof. [0142]
  • Preferred compounds of formulae (Ic) which can be used in the dyeing compositions, in accordance with the invention, are: [0143]
  • -7-amino-6-methylpyrazolo[5,1-e]tetrazole; [0144]
  • -7-amino-6-phenylpyrazolo[5,1-e]tetrazole; [0145]
  • -7-amino-6-carboxypyrazolo[5,1-e]tetrazole; [0146]
  • and the acid addition salts thereof. [0147]
  • Preferred compounds of formulae (Id) which can be used in the dyeing compositions in accordance with the invention, are: [0148]
  • -7-amino-2-methylpyrazolo[1,5-a]imidazole; [0149]
  • -7-amino-2-phenylpyrazolo[1,5-a]imidazole; [0150]
  • -7-aminopyrazolo[1,5-a]benzimidazole; [0151]
  • -7-amino-6-methylpyrazolo[1,5-a]imidazole; [0152]
  • -7-amino-2,6-dimethylpyrazolo[1,5-a]imidazole; [0153]
  • -7-amino-6-methyl-2-phenylpyrazolo[1,5-a]imidazole; [0154]
  • -7-amino-6-methylpyrazolo[1,5-a]benzimidazole; [0155]
  • -7-amino-6-phenylpyrazolo[1,5-a]imidazole; [0156]
  • -7-amino-6-phenyl-2-methylpyrazolo[1,5-a]imidazole; [0157]
  • -7-amino-2,6-diphenylpyrazolo[1,5-a]imidazole; [0158]
  • -7-amino-6-phenylpyrazolo[1,5-a]benzimidazole; [0159]
  • 7-amino-6-carboxypyrazolo[1,5-a]imidazole; [0160]
  • -7-amino-6-carboxy-2-methylpyrazolo[1,5-a]imidazole; [0161]
  • -7-amino-6-carboxy-2-phenylpyrazolo[1,5-a]imidazole; [0162]
  • -7-amino-6-carboxypyrazolo[1,5-a]benzimidazole; [0163]
  • -7-amino-6-ethoxypyrazolo[1,5-a]imidazole; -7-amino-6-ethoxy-2-methylpyrazolo[1,5-a]imidazole; [0164]
  • -7-amino-6-ethoxy-2-phenylpyrazolo[1,5-a]imidazole; [0165]
  • -7-amino-6-ethoxypyrazolo[1,5-a]benzimidazole; [0166]
  • -7-amino-6-(trifluoromethyl)pyrazolo[1,5-a]benzimidazole; [0167]
  • -7-amino-6-aminopyrazolo[1,5-a]imidazole; [0168]
  • -7-amino-6-amino-2-methylpyrazolo[1,5-a]imidazole; [0169]
  • -7-amino-6-amino-2-phenylpyrazolo[1,2-a]imidazole; [0170]
  • -7-amino-6-aminopyrazolo[1,5-a]benzimidazole; [0171]
  • -7-amino-6-(ethylthio)pyrazolo[1,5-a]imidazole; [0172]
  • -7-amino-6-ethylthio-2-methylpyrazolo[1,2-a]imidazole; [0173]
  • -7-amino-6-ethylthio-2-phenylpyrazolo[1,2-a]imidazole; [0174]
  • -7-amino-6-methyl-2-hydroxypyrazolo[1,5-a]imidazole; [0175]
  • -7-amino-6-phenyl-2-hydroxypyrazolo[1,2-a]imidazole; [0176]
  • -7-amino-6-ethoxy-2-hydroxypyrazolo[1,2-a]imidazole; [0177]
  • -7-amino-6-ethylthio-2-hydroxypyrazolo[1,5-a]imidazole; [0178]
  • -6,7-diamino-2-hydroxypyrazolo[1,5-a]imidazole; [0179]
  • and the acid addition salts thereof. [0180]
  • Preferred compounds of formulae (Ie) which can be used in the dyeing compositions in accordance with the invention, are: [0181]
  • -5,8-diamino-4-methylpyrazolo[5,1-e]pyrazole; [0182]
  • -5,7,8-triamino-4-methylpyrazolo[5,1-e]pyrazole; [0183]
  • and the acid addition salts thereof. [0184]
  • Preferred compounds of formulae (If) which can be used in the dyeing compositions in accordance with the invention, are: [0185]
  • -6-amino-5-methylpyrazolo[5,1-e]-1,2, 3-triazole; [0186]
  • -6-amino-5-phenylpyrazolo[5,1-e]-1,2,3-triazole; [0187]
  • and the acid addition salts thereof. [0188]
  • The pyrazoloazole compound(s) formula (I) preferably represent(s) from 0.0005 to 12% by weight approximately relative to the total weight of the dyeing composition, and more preferably, from 0.005 to 6% by weight, approximately, of the total weight. [0189]
  • The medium (or vehicle) suitable for dyeing is, for example, water, a water/alcohol mixture, or a mixture of water and of at least one organic solvent to dissolve any compounds which are not be sufficiently water soluble. Preferred organic solvents are, for example, C[0190] 1-C4 lower alkanols, such as ethanol and isopropanol; glycerol; glycols and glycol ethers such as 2-butoxyethanol, propylene glycol, propylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether, and aromatic alcohols, such as benzyl alcohol or phenoxyethanol, and mixtures thereof.
  • The solvents can be present in proportions ranging from 1 to 40% by weight approximately relative to the total weight of the dyeing composition, and even more preferably from 5 to 30% by weight approximately. [0191]
  • The pH of the dyeing composition in accordance with the invention generally ranges from 3 to 12, approximately, and preferably approximately from 5 to 11. It can be adjusted to the desired value by means of acidifying or basifying agents commonly used in dyeing keratinous fibers, or alternatively using conventional buffer systems. [0192]
  • Preferred acidifying agents include, for example, inorganic and organic acids, such as hydrochloric acid, orthophosphoric acid, sulphuric acid, carboxylic acids, such as acetic acid, tartaric acid, citric acid or lactic acid, and sulphonic acids. [0193]
  • Preferred basifying agents include, for example, aqueous ammonia, alkaline carbonates, alkanolamines, such as mono-, di- and triethanolamines and derivatives thereof, sodium hydroxide, potassium hydroxide, and the compounds of following formula (II): [0194]
    Figure US20020007520A1-20020124-C00009
  • in which W is a propylene residue optionally substituted by a hydroxyl radical or a C[0195] 1-C4 alkyl radical; and R6, R7, R8 and R9, which are identical or different, represent a hydrogen atom, a C1-C4 alkyl radical or C1-C4 hydroxyalkyl radical.
  • In a preferred embodiment, the dyeing composition in accordance with the invention additionally includes at least one coupler in order to modify or enrich with highlights the shades obtained by employing the compounds of formula (I). [0196]
  • The couplers which can be used in the dyeing composition in accordance with the invention may be chosen from the couplers used conventionally in oxidation dyeing, among which generally preferred couplers are: meta-phenylenediamines, meta-aminophenols, meta-diphenols and heterocyclic couplers. [0197]
  • More particularly preferred couplers are chosen from 2-methyl-5-aminophenol, 5-N-(β-hydroxyethyl)amino-2-methylphenol, 3-aminophenol, 1,3-dihydroxybenzene, 1,3-dihydroxy-2-methylbenzene, 4-chloro-1,3-dihydroxy-benzene, 2,4-diamino-1-(β-hydroxyethyloxy) benzene, 2-amino-4-(β-hydroxyethyl)amino-1-methoxybenzene, 1,3-diaminobenzene, 1,3-bis(2,4-diaminophenoxy)-propane, sesamol, α-naphthol, 6-hydroxyindole, 4-hydroxyindole, 4-hydroxy-N-methylindole, 6-hydroxyindoline, 2,6-dihydroxy-4-methylpyridine, 1H-3-methylpyrazol-5-one, 1-phenyl-3-methylpyrazol-5-one, 2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole, 2,6-dimethyl[3,2-c]-1,2,4-triazole, 6-methylpyrazolo-[1,5-a]benzimidazole, and the acid addition salts thereof. [0198]
  • When present, the coupler(s) preferably represent(s) from 0.0001 to 10% by weight approximately relative to the total weight of the dyeing composition, and even more preferably from 0.005 to 5% by weight approximately relative to this weight. [0199]
  • The dyeing composition in accordance with the invention may additionally comprise, as well as the above-defined dyes, at least one additional oxidation base chosen from the oxidation bases which are conventionally employed in oxidation dyeing, among which preferred oxidation bases are: para-phenylenediamines, bisphenylalkylenediamines, para-aminophenols, ortho-aminophenols and heterocyclic bases which are different from the pyrazoloazole compounds of formula (I) used in accordance with the invention. [0200]
  • Among the para-phenylenediamines, preferred para-phenylenediamine are: para-phenylenediamines, para-toluylenediamine, 2-chloro-para-phenylenediamine, 2,3-dimethyl-para-phenylenediamine, 2,6-dimethyl-para-phenylenediamine, 2,6-diethyl-para-phenylenediamine, 2,5-dimethyl-para-phenylenediamine, N,N-dimethyl-para-phenylenediamine, N,N-diethyl-para-phenylenediamine, N,N-dipropyl-para-phenylenediamine, 4-amino-N,N-diethyl-3-methylaniline, N,N-bis(β-hydroxyethyl)-para-phenylenediamine, 4-N,N-bis(β-hydroxyethyl)amino-2-methylaniline, 4-N,N-bis(β-hydroxyethyl)amino-2-chloroaniline, 2-(β-hydroxyethyl)-para-phenyienediamine, 2-fluoro-para-phenylenediamine, 2-isopropyl-para-phenylenediamine, N-(β-hydroxypropyl)-para-phenylenediamine, 2-hydroxymethyl-para-phenylenediamine, N,N-dimethyl-3-methyl-para-phenylenediamine, N,N-(ethyl, β-hydroxyethyl)-para-phenylenediamine, N-(β,γ-dihydroxypropyl)-para-phenylenediamine, N-(4′-aminophenyl)-para-phenylenediamine, N-phenyl-para-phenylenediamine, 2-(β-hydroxyethyloxy)-para-phenylenediamine, 2-(β-acetylaminoethyloxy)-para-phenylenediamine, N-(β-methoxyethyl)-para-phenylenediamine, and the acid addition salts thereof. [0201]
  • Among the abovementioned para-phenylenediamines, more preferred para-phenylenediamines are: para-phenylenediamine, para-toluylenediamine, 2-isopropyl-para-phenylenediamine, 2-(β-hydroxyethyl)-para-phenylenediamine, 2-(β-hydroxyethyloxy)-para-phenylenediamine, 2,6-dimethyl-para-phenylenediamine, 2,6-diethyl-para-phenylenediamine, 2,3-dimethyl-para-phenylenediamine, N,N-bis(β-hydroxyethyl)-para-phenylenediamine, 2-chloro-para-phenylenediamine, 2-(β-acetylaminoethyloxy)-para-phenylenediamine, and the acid addition salts thereof. [0202]
  • Among the bisphenylalkylenediamines, preferred bisphenylalkylenediamines are: N,N′-bis(β-hydroxyethyl)-N,N′-bis(4′-aminophenyl)-1,3-diamino-2-propanol, N,N′-bis(β-hydroxyethyl)-N,N′-bis(4′-aminophenyl)ethylenediamine, N,N′-bis(4-aminophenyl)tetramethylenediamine, N,N′-bis(β-hydroxyethyl)-N,N′-bis(4-aminophenyl)tetramethylenediamine, N,N′-bis(4-methylaminophenyl)tetramethylenediamine, N,N′-bis(ethyl)-N,N′-bis(4′-amino-3′-methylphenyl)ethylenediamine, 1,8-bis(2,5-diaminophenoxy)-3,5-dioxaoctane, and the acid addition salts thereof. [0203]
  • Among the para-aminophenols, preferred para-aminophenols are: para-aminophenol, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 4-amino-3-(hydroxymethyl)phenol, 4-amino-2-methylphenol, 4-amino-2-(hydroxymethyl)phenol, 4-amino-2-(methoxymethyl)phenol, 4-amino-2-(aminomethyl)phenol, 4-amino-2-[(β-hydroxyethyl)-aminomethyl]phenol, 4-amino-2-fluorophenol, and the acid addition salts thereof. [0204]
  • Among the ortho-aminophenols, preferred ortho-aminophenols are: 2-aminophenol, 2-amino-5-methylphenol, 2-amino-6-methylphenol, 5-acetamido-2-aminophenol, and the acid addition salts thereof. [0205]
  • Among the heterocyclic bases, preferred heterocyclic bases are: pyridine derivatives, pyrimidine derivatives and pyrazole derivatives. [0206]
  • When used, the additional oxidation base(s) preferably represent(s) from 0.0005 to 12% by weight approximately relative to the total weight of the dyeing composition and, more preferably from 0.005 to 6% by weight approximately relative to this weight. [0207]
  • The acid addition salts used within the scope of the dyeing compositions of the invention (compounds of formula (I), additional oxidation bases and couplers) are chosen in particular from hydrochlorides, hydrobromides, sulphates, citrates, succinates, tartrates, tosylates, benzenesulphonates, lactates and acetates. [0208]
  • The dyeing composition in accordance with the invention can additionally contain one or more direct dyes which can be chosen from nitrated dyes of the benzene series. [0209]
  • The dyeing composition in accordance with the invention can also contain various adjuvants used conventionally used in hair dyeing compositions, such as anionic, cationic, non-ionic, amphoteric or zwitterionic surfactants or mixtures thereof, anionic, cationic, non-ionic, amphoteric or zwitterionic polymers or mixtures thereof, inorganic or organic thickeners, antioxidants, penetration agents, sequesterants, fragrances, buffers, dispersants, conditioners such as, for example, modified or non-modified, volatile or non-volatile silicones, film formers, ceramides, preservatives or opacifiers. [0210]
  • Of course, a person skilled in the art will take care to choose the optional additional compound(s) such that the advantageous properties intrinsically associated with the dyeing composition in accordance with the invention are not, or not substantially, adversely affected by the additions envisaged. [0211]
  • The dyeing composition according to the invention may be in various forms, such as in the form of liquids, creams or gels, or any other form which is suitable for dyeing keratinous fibers, and in particular human hair. [0212]
  • Another aspect of the invention is the use of the compounds of formula (I) as defined above as oxidation base in compositions for the oxidation dyeing of keratinous is fibers, and in particular human keratinous fibers, such as hair. [0213]
  • The invention also provides a process for dyeing keratinous fibers, and in particular of human keratinous fibers such as hair using the dyeing composition as defined above. [0214]
  • According to this process, at least one dyeing composition as defined above is applied to the fibers for a period which is sufficient to develop the desired coloration, either in air or with the aid of an oxidizing agent. [0215]
  • According to one embodiment of the process of the invention, the dyeing of the fibers can be carried out without the addition of an oxidizing agent, solely by contact with the oxygen in the air. [0216]
  • In this case, the dyeing composition can optionally include oxidation catalysts in order to accelerate the oxidation process. [0217]
  • A preferred oxidation catalyst is, for example, a metal salt, such as manganese, cobalt, copper, iron, silver and zinc. A more preferred oxidation catalyst is, for example, manganese diacetate tetrahydrate, manganese dichloride, manganese triacetate and its hydrates, manganese trichloride, zinc dichloride, zinc diacetate dihydrate, zinc carbonate, zinc dinitrate, zinc sulphate, iron dichloride, iron sulphate, iron diacetate, cobalt diacetate tetrahydrate, cobalt carbonate, cobalt dichloride, cobalt sulphate heptahydrate, cupric chloride or ammoniacal silver nitrate. [0218]
  • When used, the metal salt generally represent from 0.001 to 4% by weight of relative to the total weight of the dyeing composition, and more preferably from 0.005 to 2% by weight relative to the total weight of the dyeing composition. [0219]
  • According to another embodiment of the process of the invention, at least one dyeing composition as defined above is applied to the fibers, the color being developed at an acidic, neutral or alkaline pH with the aid of an oxidizing agent which is added right at the time when the dyeing composition is employed or which is present in an oxidizing composition which is applied separately from the dye composition at the same time that said dye composition is applied to said fibers, or sequentially with the dye composition. [0220]
  • According to this embodiment of the dyeing process of the invention, the above-described dyeing composition is preferably mixed at the time of use with an oxidizing composition comprising, in a medium suitable for dyeing, at least one oxidizing agent which is present in an amount sufficient for color development. The resulting mixture is subsequently applied to the keratinous fibers and left to act for approximately 3 to 50 minutes, preferably for approximately 5 to 30 minutes, after which the fibers are rinsed, optionally washed with shampoo, rinsed again and dried. [0221]
  • The oxidizing agent present in the oxidizing composition as defined above can be chosen from the oxidizing agents conventionally used for the oxidation dyeing of keratinous fibers, among which preferred oxidizing agents are: hydrogen peroxide, urea hydrogen peroxide, alkali metal bromates, persalts, such as perborates and persulphates, and enzymes, such as peroxidases and oxidoreductases with 2 unpaired electrons. It is particularly preferred to use hydrogen peroxide. [0222]
  • The pH of the oxidizing composition comprising the oxidizing agent as defined above is such that, after it has been mixed with the dyeing composition, the pH of the resulting composition, applied to the keratinous fibers, preferably ranges from approximately 3 to 12, and more preferably from 5 to 11. The pH can be adjusted to the desired value by means of acidifying or basifying agents which are commonly used in dyeing keratinous fibers and are as defined above. [0223]
  • The oxidizing composition as defined above can also contain various adjuvants which are conventionally employed in hair-dyeing compositions and are as defined above. [0224]
  • The composition which is ultimately applied to the keratinous fibers can be in various forms, such as in the form of liquids, creams or gels, or in any other form suitable for dyeing keratinous fibers, and in particular human hair. [0225]
  • Another aspect of the invention is a multi-compartment device or “kit” or any other multi-compartment packaging system, a first compartment of which contains the dyeing composition as defined above and a second compartment of which contains the oxidizing composition as defined above. These devices may be equipped with a means for delivering the desired mixture onto the hair, such as the devices described in Patent FR-2,586,913 the disclosure of which is specifically incorporated by reference herein. [0226]
  • Certain compounds of formula (I), which are used as an oxidation base within the scope of the invention are novel and, to that extent, are further provided by the invention. [0227]
  • These novel compounds of formula (I′) and the acid addition salts thereof correspond to the following formulae (I′a) to (I′f): [0228]
    Figure US20020007520A1-20020124-C00010
  • in which R′[0229] 1, R′2, R′3 and R′4 have the same meanings as those indicated above for R1, R2, R3 and R4 of formula (I); it being understood that:
  • in the compounds of formula (I′b): [0230]
  • i) when R′[0231] 1, represents a methyl radical and when R′2 represents a hydrogen atom, then R′3 is other than a methyl radical or than a (CH2)3—SO2—(CH2)15—CH3 or CH(CH3)—CH2—SO2—(CH2)11—CH3 radical;
  • ii) when R′[0232] 1 represents a tert-butyl radical and when R′2 represents a hydrogen atom, then R′3 is other than a (CH2)3—SO2—(CH2)11—CH3 radical;
  • in the compounds of formula (I′d): [0233]
  • when R′[0234] 3 and R′4 together form a benzene radical and when R′2 represents a hydrogen atom, then R′1 is other than a methyl, —CONH2 or carboxyl radical;
  • when R′[0235] 3 and R′4 together form a benzene radical substituted by a sulphonyl radical in the 4 position and when R′2 represents a hydrogen atom, then R′1 is other than a phenyl radical, a —(CH2)16—CH3 radical or a —COOH radical;
  • when R′[0236] 3 and R′4 together form a benzene radical substituted by a carboxyl radical in the 4 position and when R′2 represents a hydrogen atom, then R′1 is other than a carboxyl radical.
  • The various compounds excluded by the above reservations are known in the photographic field or as analytical reagents (see in particular JP 02188748, JP 63074055, JP 61160745 and JP 60172982). [0237]
  • Preferred novel compounds of formula (I′a) above, are: [0238]
  • -7-amino-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0239]
  • -7-amino-2-ethylpyrazolo[1,2-b]-1,2,4-triazole; [0240]
  • -7-amino-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0241]
  • 5-7-amino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole; [0242]
  • -7-amino-2,6-dimethylpyrazolo[1,2-b]-1,2,4-triazole; [0243]
  • -7-amino-6-methyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole; [0244]
  • -7-amino-6-methyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0245]
  • -7-amino-6-methyl-2-phenylpyrazolo[1,5-b]-1,2,4-triazole; [0246]
  • -7-amino-6-carboxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0247]
  • -7-amino-6-carboxy-2-ethylpyrazolo[1,5-b]-1,2,4-triazole; [0248]
  • -7-amino-6-carboxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0249]
  • -7-amino-6-carboxy-2-phenylpyrazolo[1,2-b]-1,2,4-triazole; [0250]
  • -7-amino-6-phenyl-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0251]
  • -7-amino-6-phenyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole; [0252]
  • -7-amino-6-phenyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0253]
  • -6,7-diamino-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0254]
  • -6,7-diamino-2-ethyl pyrazolo[1,2-b]-1, 2,4-triazole; [0255]
  • -6,7-diamino-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0256]
  • -6,7-diamino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole; [0257]
  • -7-amino-6-ethylthio-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0258]
  • -7-amino-6-ethylthio-2-ethylpyrazolo[1,2-b]-1,2,4-triazole; [0259]
  • -7-amino-6-ethylthio-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0260]
  • -7-amino-6-ethylthio-2-phenylpyrazolo[1,5-b]-1,2,4-triazole; [0261]
  • -7-amino-6-ethoxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole; [0262]
  • -7-amino-6-ethoxy-2-ethylpyrazolo[1,5-b]-1,2,4-triazole; [0263]
  • -7-amino-6-ethoxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole; [0264]
  • -7-amino-6-ethoxy-2-phenylpyrazolo[1,2-b]-1,2,4-triazole; [0265]
  • -7-amino-6-methyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0266]
  • -7-amino-6-carboxy-2-(2,-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0267]
  • -7-amino-6-phenyl-2-(2′-aminoethyl)pyrazolo[1,2-b]-1,2,4-triazole; [0268]
  • -7-amino-6-ethylthio-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0269]
  • -7-amino-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0270]
  • -7-amino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0271]
  • -7-amino-6-methyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0272]
  • -7-amino-6-ethylthio-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0273]
  • -7-amino-6-carboxy-2-(2 ′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0274]
  • -7-amino-6-phenyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0275]
  • -6,7-diamino-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0276]
  • -6,7-diamino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0277]
  • -7-amino-6-ethoxy-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0278]
  • -7-amino-6-ethoxy-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; [0279]
  • and the acid addition salts thereof. [0280]
  • Preferred novel compounds of formula (I′b), are: [0281]
  • -7-amino-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0282]
  • -7-amino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0283]
  • -7-amino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0284]
  • -7-amino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0285]
  • -7-amino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0286]
  • -7-amino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0287]
  • -7-amino-6-methyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0288]
  • -7-amino-3,6-d imethylpyrazolo[3,2-c]-1,2,4-triazole; [0289]
  • -7-amino-6-methyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0290]
  • -7-amino-6-methyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0291]
  • -7-amino-6-methyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0292]
  • -7-amino-6-methyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0293]
  • -7-amino-6-methyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole; [0294]
  • -7-amino-6-phenyl-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0295]
  • -7-amino-6-phenyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0296]
  • -7-amino-6-phenyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0297]
  • -7-amino-6-phenyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0298]
  • -7-amino-6-phenyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0299]
  • -7-amino-6-phenyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0300]
  • -7-amino-6-phenyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole; [0301]
  • -7-amino-6-ethylthio-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0302]
  • -7-amino-6-ethylthio-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0303]
  • -7-amino-6-ethylthio-3-isopropylpyrazolo=3,2-c]-1,2,4-triazole; [0304]
  • -7-amino-6-ethylthio-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0305]
  • -7-amino-6-ethylthio-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0306]
  • -7-amino-6-ethylthio-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0307]
  • -7-amino-6-trifluoromethyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole; [0308]
  • -7-amino-6-(trifluoromethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0309]
  • -7-amino-6-carboxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0310]
  • -7-amino-6-carboxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0311]
  • -7-amino-6-carboxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0312]
  • -7-amino-6-carboxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0313]
  • -7-amino-6-carboxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0314]
  • -7-amino-6-carboxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0315]
  • -6,7-diamino-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0316]
  • -6,7-diamino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0317]
  • -6,7-diamino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0318]
  • -6,7-diamino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0319]
  • -7-amino-6-ethoxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole; [0320]
  • -7-amino-6-ethoxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole; [0321]
  • -7-amino-6-ethoxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole; [0322]
  • -7-amino-6-ethoxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole; [0323]
  • -7-amino-6-ethoxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0324]
  • -7-amino-6-ethoxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0325]
  • -6,7-diamino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0326]
  • -6,7-diamino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole; [0327]
  • and the acid addition salts thereof. [0328]
  • Preferred novel compounds of formula (I′c), are: [0329]
  • -7-amino-6-methyl pyrazolo[5,1-e]tetrazole; [0330]
  • -7-amino-6-phenylpyrazolo[5,1-e]tetrazole; [0331]
  • -7-amino-6-carboxypyrazolo[5,1-e]tetrazole; [0332]
  • and the acid addition salts thereof. [0333]
  • Preferred novel compounds of formula (I′d), are: [0334]
  • -7-aminopyrazolo[1,5-a]imidazole; [0335]
  • -7-amino-2-methylpyrazolo[1,5-a]imidazole; [0336]
  • -7-amino-2-phenylpyrazolo[1,5-a]imidazole; [0337]
  • -7-aminopyrazolo[1,5-a]benzimidazole; [0338]
  • -7-amino-6-methylpyrazolo[1,5-a]imidazole; [0339]
  • -7-amino-2,6-dimethylpyrazolo[1,5-a]imidazole; [0340]
  • -7-amino-6-methyl-2-phenylpyrazolo[1,5-a]imidazole; [0341]
  • -7-amino-6-phenylpyrazolo[1,5-a]imidazole; [0342]
  • -7-amino-6-phenyl-2-methylpyrazolo[1,5-a]imidazole; [0343]
  • -7-amino-2,6-diphenylpyrazolo[1,5-a]imidazole; [0344]
  • -7-amino-6-phenylpyrazolo[1,5-a]benzimidazole; [0345]
  • -7-amino-6-carboxypyrazolo[1,5-a]imidazole; [0346]
  • -7-amino-6-carboxy-2-methylpyrazolo[1,5-a]imidazole; [0347]
  • -7-amino-6-carboxy-2-phenylpyrazolo[1,2-a]imidazole; [0348]
  • -7-amino-6-ethoxypyrazolo[1,5-a]imidazole; [0349]
  • -7-amino-6-ethoxy-2-methylpyrazolo[1,5-a]imidazole; [0350]
  • -7-amino-6-ethoxy-2-phenylpyrazolo[1,5-a]imidazole; [0351]
  • -7-amino-6-ethoxypyrazolo[1,5-a]benzimidazole; [0352]
  • -7-amino-6-(trifluoromethyl)pyrazolo[1,5-a]benzimidazole; [0353]
  • -7-amino-6-aminopyrazolo[1,5-a]imidazole; [0354]
  • -7-amino-6-amino-2-methylpyrazolo[1,5-a]imidazole; [0355]
  • -7-amino-6-amino-2-phenylpyrazolo[1,5-a]imidazole; [0356]
  • -7-amino-6-aminopyrazolo[1,5-a]benzimidazole; [0357]
  • -7-amino-6-(ethylthio)pyrazolo[1,5-a]imidazole; [0358]
  • -7-amino-6-ethylthio-2-methylpyrazolo[1,5-a]imidazole; [0359]
  • -7-amino-6-ethylthio-2-phenylpyrazolo[1,5-a]imidazole; [0360]
  • -7-amino-6-methyl-2-hydroxypyrazolo[1,5-a]imidazole; [0361]
  • -7-amino-6-phenyl-2-hydroxypyrazolo[1,5-a]imidazole; [0362]
  • -7-amino-6-ethoxy-2-hydroxypyrazolo[1,5-a]imidazole; [0363]
  • -7-amino-6-ethylthio-2-hydroxypyrazolo[1,5-a]imidazole; [0364]
  • -6,7-diamino-2-hydroxypyrazolo[1,5-a]imidazole; [0365]
  • and the acid addition salts thereof. [0366]
  • Preferred novel compounds of formula (I′e), are: [0367]
  • -5,8-diamino-4-methylpyrazolo[5,1-e]pyrazole; [0368]
  • -5,7,8-triamino-4-methylpyrazolo[5,1-e]pyrazole; [0369]
  • and the acid addition salts thereof. [0370]
  • Preferred novel compounds of formula (I′f), are: [0371]
  • -6-amino-5-methylpyrazolo[5,1-e]-1,2,3-triazole; [0372]
  • -6-amino-5-phenylpyrazolo[5,1-e]-1,2,3-triazole; [0373]
  • and the acid addition salts thereof. [0374]
  • The novel compounds of formula (I′) in accordance with the present invention can be prepared according to the methods described in the following patent applications and patents: FR 2,075,583, EP-A-119,860, EP-A-285,274, EP-A-244,160, EP-A-578,248, GB 1,458,377, U.S. Pat. No. 3,227,554, US 3,419,391, US 3,061,432, US 4,500,630, US 3,725,067, US 3,926,631, US 5,457,210, JP 84/99437, JP 83/42045, JP 84/162548, JP 84/171956, JP 85/33552, JP 85/43659, JP 85/172982, JP 85/190779, JP 41/33053, EP 433,854, JP 62/129851 JP 60/140241, as well as in the following publications: [0375]
  • Chem. Ber., 32, 797 (1899), Chem. Ber., 89, 2550 (1956), [0376]
  • J. Chem. Soc. Perkin Trans. I, 2047 (1977), [0377]
  • J. Prakt. Chem., 320, 533 (1978). [0378]
  • The following examples are intended to illustrate the invention, without, however, limiting its scope. [0379]
    • PREPARATION EXAMPLES Preparation Example A Synthesis of 1H-7-amino-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole Hydrochloride
  • [0380]
    Figure US20020007520A1-20020124-C00011
  • 200 g (1.23 mol) of ethyl orthoacetate were added over 20 minutes at room temperature to a solution of 100 g of 5-amino-3-methylpyrazole (1.03 mol) in 500 cm[0381] 3 of diglyme. The reaction mixture was heated at 95° C. and then concentrated at 55° C. under 300 Pa, in order to obtain 164 g of an orange oil corresponding to product A.
  • 180 cm[0382] 3 of a sodium methoxide solution (5.7M in methanol) were added at room temperature to a solution of 71.7 g (1.03 mol) of hydroxylamine hydrochloride in 1.5 l of absolute ethanol. After stirring for 30 minutes, the reaction mixture was cooled to 5° C. and filtered. The salts were washed 2 times with 100 cm3 of absolute ethanol and the two ethanol washes were combined. 164 g (0.98 mol) of compound A, prepared as above, dissolved in 150 cm3 of ethanol, were added to this solution at a temperature of The reaction mixture was allowed to warm up again to room temperature and stirred for an additional 1 h. The reaction mixture was then cooled to 5° C. and the precipitate obtained was filtered off, washed with 2 times 100 cm3 of isopropyl ether and dried at 50° C. under 5300 Pa. 52 g of a first crop of white solid were thus obtained, which solid corresponds to the compound B, the melting point of which was 197° C.
  • The ethanol filtrate and the ether washes were combined and then concentrated to dryness before being titrated in 300 cm[0383] 3 of tetrahydrofuran. This second precipitate was filtered, washed with isopropyl ether and dried at 50° C. under vacuum to yield 16 g of a second crop of white precipitate with a melting point of 197° C. corresponding to the compound B. 20.05 cm3 (0.143 mol) of anhydrous triethylamine and 27.2 g (0.143 mol) of the acid chloride of para-toluenesulphonic acid were added to a solution of 20 g (0.13 mol) of compound B, prepared above, in 9.5 liters of anhydrous tetrahydrofuran. The reaction mixture was stirred for 2 hours at room temperature and then cooled to 0° C. The triethylamine hydrochloride was separated by filtration and the filtrate was concentrated under a vacuum of 8 kPa at approximately 50° C. until the beginning of crystallization. Cooling was carried out to 0° C. and the precipitate was filtered off on a sintered glass, washed with ice-cold tetrahydrofuran and then dried under vacuum at a temperature of 40° C. 38.2 g of compound C were thus obtained in the form of a white solid, the melting point of which was between 105° C. and 128° C. (decomposition).
  • A solution of 35 g (0.113 mol) of compound C obtained above in 1 liter of methanol was heated at reflux for 2 hours and then the solution was evaporated to dryness. An oil was obtained which crystallized when 100 cm[0384] 3 of isopropyl ether were added. The crystals were filtered off on a sintered glass and then recrystallized from a mixture of isopropanol and heptane. After drying under a vacuum at 40° C., 19 g of 1H-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole tosylate (compound D) were obtained in the form of a white solid, the melting point of which was 157° C.
  • 8.9 cm[0385] 3 of fuming nitric acid were added, taking care not to exceed a temperature of 5° C., to a solution of 19 g (0.062 mol) of compound D in 35 cm3 of concentrated sulphuric acid at a temperature ranging from 0° C. to 5° C. The reaction mixture was subsequently heated to room temperature, stirred for 4 hours and then slowly poured onto 400 g of crushed ice. The white solid which precipitated was filtered off, washed 2 times with 15 cm3 of ice-cold water and dried at 40° C. under vacuum. 8.5 g of white solid, which corresponds to compound E with a melting point of 273° C., were thus obtained.
  • 1.4 g of 5% by weight palladium-on-charcoal comprising 50% water were added to a solution of 8 g (0.044 mol) of compound E in 300 cm[0386] 3 of methanol. The suspension was placed in a hydrogenator under a pressure of 13 bar of hydrogen and at a temperature of 70° C. for 5 hours. The contents of the hydrogenator were withdrawn and filtered on a sintered glass. The filtrate was subsequently added to 100 cm3 of a 4M ethanolic hydrochloric acid solution. 350 cm3 of ethyl ether were added to this solution and the precipitate that formed was filtered off, washed twice with 20 cm3 of ethyl ether and dried at 40° C. under vacuum to produce 7.2 g of beige solid corresponding to compound F with a melting point of 213° C.
  • The elemental analysis for C[0387] 6H9N5.HCl was:
    % C H N Cl
    Calculated 38.41 5.37 37.32 18.89
    Found 38.22 5.14 36.57 19.03
    • Preparation Example B Synthesis of 1H-7-amino-3,6-dimethylpyrazolo[3,2-c]-1,2,4-triazole Dihydrochloride
  • [0388]
    Figure US20020007520A1-20020124-C00012
  • 113.5 g (0.754 mol) of methyl 2-chloroacetoacetate (compound G) were added at a temperature of 80° C. to a solution of 80 g of thiocarbazide (0.754 mol) in 2 liters of ethanol and 700 cm[0389] 3 of 12N hydrochloric acid. The reaction mixture was heated at reflux for 1 hour and then cooled to 0° C. The solid that formed was filtered off, washed twice with 200 cm3 of isopropyl ether and then dried at 40° C. under vacuum. The solid was then dissolved in 800 cm3 of methanol at reflux and the solution was cooled to 0° C. The solid thus formed was filtered off, washed twice with 100 cm3 of isopropyl ether and dried at 40° C. under vacuum. 12.65 g of beige powder, which corresponds to compound H and has a melting point of 199° C., were thus obtained.
  • The recrystallized filtrate was concentrated by half and 700 cm[0390] 3 of isopropyl ether were added to this concentrate. The solid thus formed was filtered off, washed twice with 100 cm3 of isopropyl ether and dried at 40° C. under vacuum. 9.14 g of beige solid, which corresponds to compound H and has a melting point of 200° C., were thus obtained. The same protocol was followed on the latter filtrate and 6.9 g of a beige solid were obtained, which corresponds to compound H with a melting point of 199° C.
  • 9.7 cm[0391] 3 of acetic anhydride were added to a suspension of 25 g (0.103 mol) of compound H in 750 cm3 of acetic acid. The reaction mixture was heated at reflux for 1 hour and then cooled to 16° C. The white precipitate was then filtered off, washed with 250 cm3 of diisopropyl ether and dried at 40° C. under vacuum. 19 g of white solid, which corresponds to compound I and has a melting point of 216° C., were thus obtained. The filtrate was concentrated to a volume of approximately 30 cm3 and then cooled to 16° C. 15 cm3 of acetone and 45 cm3 of isopropyl ether were added to this solution. The precipitate was then filtered off, washed twice with 50 cm3 of isopropyl ether and dried at 40° C. under vacuum. 4.7 g of a second crop of white precipitate, which corresponds to compound I and has a melting point of 216° C., were thus obtained.
  • 22 cm[0392] 3 of phosphoryl chloride were added at room temperature and with vigorous stirring to a suspension of 23 g of compound 1 (0.092 mol) in 1.2 liters of toluene. The reaction mixture was heated at reflux for 5 hours and then cooled to 0° C. The precipitate obtained was filtered off, washed twice with 200 cm3 of heptane and dried under a pressure of 40 mm of mercury at 40° C. 11 g of yellow precipitate were thus obtained and were recrystallized from 30 cm3 of absolute ethanol, in order to yield 5 g of yellow powder corresponding to compound J with a melting point of 192° C.
  • 1.7 cm[0393] 3 of 10N sodium hydroxide solution were added at a temperature of 5° C. to a solution of 3.8 g (0.016 mol) of compound J in 20 cm3 of water. 60 cm3 of 98% concentrated sulphuric acid were added to this solution, taking care that the temperature remained between 7 and 10° C. The reaction mixture was subsequently heated at 100° C.-120° C. for 1 h 30. After cooling to 0° C., the reaction mixture was poured into 200 g of ice and its pH was adjusted to pH 8 using 10N sodium hydroxide solution, taking care that the temperature did not exceed 10° C.
  • The aqueous phase was subsequently extracted 3 times with 300 cm[0394] 3 of ethyl acetate. The organic phase was dried over sodium sulphate and concentrated to a volume of approximately 30 cm3. The yellow precipitate obtained was filtered off, washed twice with 50 cm3 of heptane and dried at 40° C. under vacuum. 1.2 g of yellow powder, which corresponds to compound K and has a melting point of 118° C., were thus obtained. 4N hydrochloric acid was added to a solution of 1 g of compound K (7.3 mmol) in 20 cm3 of isopropanol and 20 cm3 of absolute ethanol until the pH of the solution was 5. The reaction mixture was cooled to 5° C. and 1 cm3 of isopentyl nitrite was added thereto. The temperature of the reaction mixture was brought to 25° C. After stirring for 1 hour, the reaction mixture was cooled to 0° C. and the precipitate was filtered off, washed with diisopropyl ether and dried at 30° C. under vacuum. 1.2 g of beige solid, which corresponds to compound L and has a melting point of 210° C., were thus obtained.
  • 0.4 g of 5% by weight palladium-on-charcoal comprising 50% water was added to a solution of 1 g (6 mmol) of compound L in 200 cm[0395] 3 of methanol. The suspension was placed in a hydrogenator under a pressure of 3.5 bar of hydrogen at 30° C. for 1 hour. The contents of the hydrogenator were subsequently removed and filtered. The filtrate was run into a solution comprising 200 cm3 of diisopropyl ether and 10 cm3 of 5M ethanolic hydrochloric acid solution. The precipitate formed was filtered off, washed with diisopropyl ether and dried at 40° C. under vacuum. 0.9 g of light beige powder, which corresponds to compound M and has a melting point of 206° C., was thus obtained and was named, with the numbering conventions defined above, 7-amino-3,6-dimethylpyrazolo[3,2-c]-1,2,4-triazole dihydrochloride.
  • The elemental analysis for C[0396] 6H9N5.2HCl.H2O was:
    % C H N Cl
    Calculated 29.77 5.41 28.93 29.29
    Found 29.07 5.19 28.04 29.48
    • Preparation Example C Synthesis of 1H-7-amino-6-methylpyrazolo[1,5-a]imidazole Dihydrochloride
  • [0397]
    Figure US20020007520A1-20020124-C00013
  • 685 g of hydrazine hydrochloride (10 mol) were added to a solution of 410 g of sodium hydroxide in 6 liters of n-propanol at 25° C. After stirring for 1 hour, 452 g of potassium carbonate (3.27 mol) were introduced at room temperature, followed by 1 kg of chloroacetaldehyde diethyl acetal. The reaction mixture was heated at boiling point for 40 hours and then cooled to 5° C. The precipitated salts were filtered off and washed twice with 200 cm[0398] 3 of absolute ethanol. The combined filtrate and ethanolic phase were concentrated until a yellow oil was obtained, which oil was distilled under a pressure of 1.3 Pa at a temperature of 78-82° C. 446 g of colorless oil, which corresponds to compound N, were thus isolated.
  • 14.8 g (0.1 mol) of compound N, diluted beforehand in 20 cm[0399] 3 of n-pentanol, were added at 25° C. to a solution of 8.2 g (0.1 mol) of 3-aminocrotononitrile in 100 cm3 of n-pentanol. The reaction mixture was heated at reflux for 5 hours and then concentrated to distil off the n-pentanol under a pressure of 5.3 kPa. The brown oil which was obtained was subsequently distilled under a vacuum of 3 Pa at a temperature of 117-119° C., in order to isolate a pale yellow oil. 17.8 g of oil, which corresponds to compound 0, were thus obtained.
  • 200 cm[0400] 3 of 20% aqueous sulphuric acid were added at room temperature to a solution of 17 g (0.08 mol) of compound 0 in 300 cm3 of absolute ethanol. The reaction mixture was subsequently heated at reflux for 3 hours and then cooled to 5° C. The pH of the reaction mixture was adjusted to pH 8 using a saturated solution of sodium hydrogencarbonate in water. The sodium sulphate salt was filtered from the reaction mixture and the filtrate was concentrated, to remove the ethanol. The aqueous phase thus obtained was extracted 3 times with 300 cm3 of ethyl acetate and then with 300 cm3 of an ethyl acetate/methanol mixture in the proportions of 90/10. The combined organic phases were dried over magnesium sulphate and then concentrated to dryness. The orange solid obtained was subsequently triturated in 200 cm3 of heptane, filtered off and washed with 50 cm3 of heptane, and then dried at 40° C. under vacuum. 9.8 g of orange solid, which corresponds to compound P and has a melting point of 138° C., were thus obtained.
  • 12N hydrochloric acid was added to a solution of 2 g (0.016 mol) of compound P in 10 cm[0401] 3 of absolute ethanol at 5° C. until the reaction mixture reached a pH of 5-6. 2.2 cm3 (0.016 mol) of isoamyl nitrite were then added to this solution at 5° C. and the temperature of the reaction mixture was gradually increased to approximately 20° C. After stirring for 1 hour, the suspension was cooled to 5° C. and the precipitate was filtered off, washed twice with 20 cm3 of heptane and dried at 35° C. under vacuum. 1.4 g of red-brown solid, which corresponds to compound Q and has a melting point of 216° C., were thus obtained.
  • 0.3 g of 5% palladium-on-charcoal comprising 50% water was added to a solution of 1 g (6.66 mmol) of compound Q in 150 cm[0402] 3 of methanol. The suspension was placed in a hydrogenator under a pressure of 1.5 bar at 30° C. for 1 h 30. The contents of the hydrogenator were subsequently withdrawn and filtered. The filtrate was run into a solution comprising 100 cm3 of isopropyl alcohol and 10 cm3 of 5M ethanolic hydrochloric acid. The solution was concentrated to a volume corresponding to the volume used at beginning of the crystallization of the reduced product. The suspension was then cooled to ice-cold temperatures, and the precipitate was filtered off, washed with ice-cold isopropanol and dried at 40° C. under vacuum. 0.55 g of light beige solid, which corresponds to compound R and has a decomposition point between 230° and 250° C., was thus obtained and was named, with the numbering conventions defined above, 7-amino-6-methylpyrazolo[1,5-a]imidazole dihydrochloride.
  • The elemental analysis for C[0403] 6H8N4.2HCl was:
    % C H N Cl
    Calculated 34.47 4.82 26.80 33.91
    Found 33.99 4.84 25.69 35.08
    • DYEING EXAMPLES Example 1 of Dyeing in Alkaline Medium
  • The following dyeing composition was prepared: [0404]
    7-amino-3,6-dimethylpyrazolo[3,2-c]-1,2,4- 0.672 g
    triazole dihydrochloride monohydrate
    (compound of formula (I))
    Resorcin 0.330 g
    Benzyl alcohol 2 g
    Polyethylene glycol with 6 mol of 3 g
    ethylene oxide
    Ethanol 18 g
    (C8-C10)alkyl polyglucoside as a 60% 6 g
    aqueous solution of active material
    buffered with ammonium citrate, sold under
    the name ORAMIX CG110 ® by Seppic
    Aqueous ammonia comprising 20% of NH3 10 g
    Sodium metabisulphite 0.208 g
    Sequestering agent q.s.
    Demineralized water q.s. for 100 g
  • At the time of use, the above dyeing composition was mixed weight for weight with an oxidizing composition composed of an aqueous solution comprising 6×10[0405] −3 mol % of ammonium persulphate. The mixture obtained exhibited a pH of approximately 9.7 and was applied to locks of natural grey hair containing 90% of white hairs for 30 minutes. The hair was subsequently rinsed, washed with a standard shampoo and dried.
  • The hair was dyed in an ash iridescent shade. [0406]
    • Examples 2 and 3 of Dyeing in Alkaline Medium
  • The following dyeing compositions were prepared (contents in grams): [0407]
    EXAMPLE 2 3
    7-Amino-6-methylpyrazolo[1,5-a]benzimidazole.2HCl 1.43 —
    (Compound of formula (I))
    7-Amino-3,6-dimethylpyrazolo[3,2-c]-1,2,4- — 1.12
    triazole.2HCl.H2O
    (Compound of formula (I))
    Common dyeing vehicle No. 1 (*) (*)
    Demineralized water, q.s. for 100 g 100 g
    (*) Common dyeing vehicle No. 1:
    - Benzyl alcohol 3 g
    - Polyethylene glycol with 6 mol 4.5 g
    of ethylene oxide
    - Ethanol 15 g
    - (C8-C10)alkyl polyglucoside as a 60% 9 g
    aqueous solution of active material
    buffered with ammonium citrate, sold under
    the name ORAMIX CG110 ® by Seppic
    - Ammoniacal buffer (1 M NH4OH/1 M NH4Cl) 24 g
  • These compositions had a pH of approximately 9.5 and were applied to locks of natural grey hair containing 90% of white hairs for 30 minutes. [0408]
  • The coloring developed without any other oxidizing agent than atmospheric oxygen. The hair was subsequently rinsed, washed with a standard shampoo and dried. [0409]
  • The hair was dyed in a shade which appears in the table below: [0410]
    EXAMPLE SHADE OBTAINED
    2 Toned-down iridescent red
    3 Coppery golden
    • Example 4 of Dyeing in Neutral Medium
  • The following dyeing composition was prepared: [0411]
    7-Amino-3,6-dimethylpyrazolo[3,2-c]- 1.12 g
    1,2,4-triazole.2HCl.H2O
    (compound of formula (I))
    Benzyl alcohol 3 g
    Polyethylene glycol with 6 mol of 4.5 g
    ethylene oxide
    Ethanol 15 g
    (C8-C10)alkyl polyglucoside as a 60% 9 g
    aqueous solution of active material
    buffered with ammonium citrate, sold under
    the name ORAMIX CG110 ® by Seppic
    Phosphate buffer (1.5M K2HPO4/1M KH2PO4) 24 g
    Demineralized water q.s.for 100 g
  • This composition had a pH of approximately 7 and was applied to locks of natural grey hair containing 90% of white hairs for 30 minutes. [0412]
  • The coloring developed without any other oxidizing agent than atmospheric oxygen. The hair was subsequently rinsed, washed with a standard shampoo and dried. [0413]
  • The hair was dyed in a golden coppery shade. [0414]
    • Examples 5 and 6 of Dyeing in Alkaline Medium
  • The following dyeing compositions were prepared (contents in grams): [0415]
    EXAMPLE 5 6
    7-Amino-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole.HCl 0.726 0.726
    (Compound of formula (I))
    2-Methyl-5-aminophenol (coupler) 0.369 —
    meta-Aminophenol — 0.327
    Common dyeing vehicle No.2 (**) (**)
    Demineralized water, q.s. for 100 g 100 g
    (**) Common dyeing vehicle No. 2:
    - Ethanol 30 g
    - Ammonium acetate 0.8 g
    - Sodium metabisulphite as a 35% 1.3 g
    aqueous solution
    - Aqueous ammonia comprising 20% of NH3 q.s. for pH 10
  • At the time of use, the dyeing composition of Example 5 was mixed weight for weight with a 20-volume hydrogen peroxide solution (6% by weight) with a pH of 3. The mixture obtained exhibited a pH of approximately 9.9. [0416]
  • At the time of use, the dyeing composition of Example 6 was mixed weight for weight with an aqueous solution comprising 6×10[0417] −3 mol % of ammonium persulphate. The mixture obtained exhibited a pH of approximately 9.7.
  • Each of the mixtures obtained was applied for 30 minutes to locks of natural grey hair containing 90% of white hairs. The hair was subsequently rinsed, washed with a standard shampoo, rinsed again and then dried. [0418]
  • The hair was dyed in a shade which appears in the table below: [0419]
    EXAMPLE SHADE OBTAINED
    5 Salmon
    6 Fuchsia
    • Examples 7 to 12 of Dyeing in Acidic Medium
  • The following dyeing compositions were prepared (contents in grams): [0420]
    EXAMPLE 7 8 9 10 11 12
    7-Amino-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole.HCl 0.726 0.726 — — — —
    (compound of formula (I))
    1H-7-Aminopyrazolo[1,5-a]imidazole.2HCl — — 0.585 0.585 0.585 —
    (compound of formula (I))
    1H-7-Amino-6-methylpyrazolo[1,5-a]imidazole.2HCl — — — — — 0.627
    (compound of formula (I))
    2,4-Diaminophenoxyethanol dihydrochloride 0.723 — 0.723 — 0.723 0.723
    (coupler)
    2-Methyl-5-aminophenol (coupler) — 0.369 — — — —
    meta-Aminophenol (coupler) — — — 0.327 — —
    Common dyeing vehicle No. 3 (**) (**) (***) (***) (***) (***)
    Demineralized water, q.s. for 100 g 100 g 100 g 100 g 100 g 100 g
    (***) Common dyeing vehicle No. 3:
    - Ethanol 20 g
    - K2HPO4/KH2PO4 (1.5M/1M) buffer 10 g
    - Sodium metabisulphite as a 50% 1.3 g
    aqueous solution
  • At the time of use, the dyeing compositions of Examples 7, 8 and 10 to 12 were mixed weight for weight with a 20-volume hydrogen peroxide solution (6% by weight). [0421]
  • At the time of use, the dyeing composition of Example 9 was mixed weight for weight with an aqueous solution comprising 6×10[0422] −3 mol % of ammonium persulphate.
  • Each of the mixtures obtained was applied for 30 minutes to locks of natural grey hair containing 90% of white hairs. The hair was subsequently rinsed, washed with a standard shampoo, rinsed again and then dried. [0423]
  • The hair was dyed in a shade which appears in the table below: [0424]
    EXAMPLE Dyeing pH Shade obtained
     7 6.4 ± 0.2 Purple
     8 6.1 ± 0.2 Pinkish orangey
     9 3.2 ± 0.2 Purplish ash
    10 6.2 ± 0.2 Coppery red
    11 5.5 ± 0.2 Deep purple
    12 5.5 ± 0.2 Deep purple

Claims (75)

What is claimed is:
1. A composition for the oxidation dyeing of keratinous fibers, wherein said composition comprises, in a medium suitable for dyeing:
as oxidation base, at least one pyrazoloazole compound of formula (I) or at least one acid addition salt thereof:
Figure US20020007520A1-20020124-C00014
in which:
R1 represents: a hydrogen atom; a linear or branched C1-C20 alkyl radical, optionally substituted by 1 or 2 radicals R chosen from a halogen atom, a nitro radical, a cyano radical, a hydroxyl radical, an alkoxy radical, an aryloxy radical, an amino radical, an alkylamino radical, an acylamino radical, a carbamoyl radical, a sulphonamido radical, a sulphamoyl radical, an imido radical, an alkylthio radical, an arylthio radical, an aryl radical, a (C1-C4)alkoxy-carbonyl radical and an acyl radical; an aryl radical optionally substituted by 1 or 2 radicals R as defined above; a 5- or 6-membered heterocycle containing at least one nitrogen, oxygen or sulphur atom wherein said heterocycle is optionally substituted by 1 or 2 radicals R as defined above;
when R1 denotes a C1-C4 alkyl radical, an aryl radical or a 5- or 6-membered heterocycle, it can be connected to the carbon atom of the pyrazole via an oxygen, nitrogen or sulphur atom;
R1 can, additionally, denote a halogen atom; an acyl radical; a sulphonyl radical; a sulphinyl radical; a phosphonyl radical; a carbamoyl radical; a sulphamoyl radical; a cyano radical; a siloxy radical; an amino radical; an acylamino radical; an acyloxy radical; a carbamoyloxy radical; a sulphonamide radical; an imide radical; a ureido radical; a sulphamoylamino radical; a (C1-C4)alkoxy-carbonylamino radical; an aryloxycarbonylamino radical; a (C1-C4)alkoxy-carbonyl radical; an aryloxycarbonyl radical; a carboxyl radical; or a hydroxyl radical;
R2 is a hydrogen atom; a C1-C4 alkyl radical; a C1-C4 monohydroxyalkyl radical; a C2-C4 polyhydroxyalkyl radical; a C1-C4 aminoalkyl radical; a (CH2)p—X—(CH2)qOR′ radical in which p and q are identical or different integers ranging from 1 to 3, R′ represents a hydrogen atom or a methyl radical, and X denotes an oxygen atom or an NR″ group in which R″ represents a hydrogen atom or a methyl radical; a (C1-C4)alkoxy(C2-C4)alkyl radical; or a di(C1-C4)alkylamino(C1-C4)alkyl radical;
Za, Zb and Zc represent, independently of one another, a nitrogen atom or a carbon atom carrying an R3 or R4 radical, where R3 and R4 independently have the same meanings as those indicated above for R1, with the proviso that at least one of the Za, Zb and Zc radicals is other than a carbon atom; R3 and R4 can also together form a substituted or unsubstituted aromatic ring, such as a phenyl ring.
2. A composition according to claim 1, wherein said keratinous fibers are human keratinous fibers.
3. A composition according to claim 2, wherein said human keratinous fibers are hair.
4. A composition according to claim 1, wherein, when R1 represents a linear or branched C1-C20 alkyl radical substituted by one or two radicals R wherein R is an aryl radical or when R1 is an aryl radical, said aryl radical is phenyl or naphthyl.
5. A composition according to claim 1, wherein R1 represents a 5 or 6 membered heterocycle containing at least one nitrogen, oxygen or sulphur atom and wherein said heterocycle is pyridyl, quinolyl, pyrrolyl, morpholyl, furanyl, tetrahydorfuranyl, pyrazolyl, triazolyl, thiazolyl, oxazolyl, imidazolyl or thiadiazolyl.
6. A composition according to claim 1, wherein R1 is a halogen atom and wherein said halogen is bromine, chlorine, or fluorine.
7. A composition according to claim 1, wherein R1 is a hydrogen atom; a linear or branched C1-C4 alkyl radical; a phenyl ring; a phenyl ring substituted by a halogen atom, a C1-C4 alkyl radical, a C1-C4 alkoxy radical, a nitro radical, an amino radical, a trifluoromethyl radical or by a C1-C4 alkylamino radical; a benzyl radical; a benzyl radical substituted by a halogen atom, a C1-C4 alkyl radical, a C1-C4 alkoxy radical, a nitro radical, an amino radical, a trifluoromethyl radical or by a C1-C4 alkylamino radical; a heterocycle chosen from thiophene, furan or pyridine rings; a trifluoromethyl radical; a (CH2)p—X—(CH2)q—OR′ radical in which p and q are identical or different integers ranging from 1 to 3, R′ represents a hydrogen atom or a methyl radical and X denotes an oxygen atom or an NR″ radical in which R″ denotes a hydrogen atom or a methyl radical; a C1-C4 hydroxyalkyl radical; a C1-C4 aminoalkyl radical; a C1-C4 alkylamino radical; a di(C1-C4)alkylamino radical; an arylamino radical; an alkoxy radical chosen from methoxy, ethoxy and phenoxy; a halogen atom chosen from bromine, chlorine and fluorine; a carboxyl radical; a C1-C4 alkoxycarbonyl radical; a phenyloxycarbonyl radical; a methylthio radical; an ethylthio radical; a phenylthio radical; a methanesulphonyl radical; a cyano radical; an amino radical; or a hydroxyl radical.
8. A composition according to claim 7, wherein R1 is a hydrogen atom; an alkyl radical chosen from methyl, ethyl, isopropyl and tert-butyl radicals; a halogen atom chosen from chlorine and fluorine; a phenyl radical; a toluyl radical; a 4-chlorophenyl radical; a 4-methoxyphenyl radical; a 3-methoxyphenyl radical; a 2-methoxyphenyl radical; a benzyl radical; a heterocycle chosen from pyridyl, furyl and thienyl rings; a trifluoromethyl radical, a hydroxymethyl radical; an aminomethyl radical; a methoxy radical; an ethoxy radical; a methylamino radical; an ethylamino radical; a dimethylamino radical; a carboxyl radical; a methoxycarbonyl radical; an ethoxycarbonyl radical or a cyano radical.
9. A composition according to claim 8, wherein R1 a hydrogen atom; a chlorine atom; a methyl radical; an ethyl radical; a phenyl radical; a toluyl radical; a 4-chlorophenyl radical; a 4-methoxyphenyl radical; a benzyl radical; a trifluoromethyl radical; a methoxy radical; an ethoxy radical; a carboxyl radical; a methylamino radical; a dimethylamino radical or a cyano radical.
10. A composition according to claim 1, wherein R2 is of a hydrogen atom; a methyl radical or a β-hydroxyethyl radical.
11. A composition according to claim 10, wherein R2 is a hydrogen atom.
12. A composition according to claim 1, wherein R3 and R4 are independently a hydrogen atom; a hydroxyl radical; an amino radical; a linear or branched C1-C4 alkyl radical; a trifluoromethyl radical; a phenyl ring; a phenyl ring substituted by one or two radicals R chosen from a halogen atom, a C1-C4 alkyl radical, a C1-C4 alkoxy radical, a hydroxyl radical, a carboxyl radical, a nitro radical, a C1-C4 alkylthio radical, a methylenedioxy radical, an amino radical, a trifluoromethyl radical and a C1-C4 alkylamino radical; a benzyl radical; a benzyl radical substituted by a halogen atom, a methyl or isopropyl radical or a methoxy radical; a C1-C4 monohydroxyalkyl radical; a C1-C4 aminoalkyl radical; a (C1-C4)alkylamino(C1-C4)alkyl radical; an alkoxy radical chosen from methoxy, ethoxy and phenoxy radicals; a methylthio radical; an ethylthio radical; a phenylthio radical; a methanesulphonyl radical; or a substituted or unsubstituted aromatic ring formed jointly by R3 and R4.
13. A composition according to claim 12, wherein R3 and R4 jointly form a substituted or unsubstituted aromatic ring, said ring being a phenyl ring, pyridyl ring or phenyl ring substituted by a sulphonyl radical, a halogen atom, a C1-C4 alkoxy radical, a C1-C4 alkyl radical, a nitro radical, a cyano radical, an amino radical, a C1-C4 alkylamino radical or a trifluoromethyl radical.
14. A composition according to claim 12, wherein R3 and R4 are independently a hydrogen atom; an alkyl radical chosen from methyl, ethyl, isopropyl, n-propyl and tert-butyl radicals; a phenyl ring; a toluyl ring; a 2-, 3- or 4-chlorophenyl ring; a 3- or 4-hydroxyphenyl ring; a 3- or 4-aminophenyl ring; a 3- or 4-methoxyphenyl ring; a 4-trifluoromethylphenyl ring; a benzyl ring; a trifluoromethyl radical; a hydroxymethyl radical; a hydroxyethyl radical; a hydroxyisopropyl radical; an aminomethyl or aminoethyl radical; a methoxy or ethoxy radical; a methylthio or ethylthio radical; or a substituted or unsubstituted aromatic ring formed jointly by R3 and R4.
15. A composition according to claim 14, wherein R3 and R4 jointly form a substituted or unsubstituted aromatic ring, said ring being a phenyl, toluyl, sulphonylphenyl or chlorophenyl ring.
16. A composition according to claim 14, wherein R3 and R4 independently are a hydrogen atom; a methyl radical; an ethyl radical; an isopropyl radical; a phenyl ring; a 4-chlorophenyl ring; a 4-methoxyphenyl ring; a 4-aminophenyl ring; a methoxy or ethoxy radical; a methylthio or ethylthio radical; or R3 and R4 jointly form a phenyl ring.
17. A composition according to claim 1, wherein said at least one compound of formula (I) is chosen from:
i) pyrazolo[1,5-b]-1,2,4-triazoles of formula (Ia) and the acid addition salts thereof:
Figure US20020007520A1-20020124-C00015
ii) pyrazolo[2,3-c]-1,2,4-triazoles of formula (Ib) and the acid addition salts thereof:
Figure US20020007520A1-20020124-C00016
iii) pyrazolotetrazoles of formula (Ic) and the acid addition salts thereof:
Figure US20020007520A1-20020124-C00017
iv) pyrazolo[1,5-a]imidazoles of formula (Id) and the acid addition salts thereof:
Figure US20020007520A1-20020124-C00018
v) pyrazolo[5,1-e]pyrazoles of formula (Ie) and the acid addition salts thereof:
Figure US20020007520A1-20020124-C00019
vi) pyrazolo[5,1-e]-1,2,3-triazoles of formula (If) and the aicd addition salts thereof:
Figure US20020007520A1-20020124-C00020
in which R1, R2, R3 and R4 have the same meanings as those indicated in claim 1.
18. A composition according to claim 17, wherein said pyrazolo[1,5-b]-1,2,4-triazoles of formula (Ia) or said pyrazolo[3,2-c]-1,2,4-triazoles of formula (Ib) are chosen from those compounds in which:
R1 is a hydrogen atom or a methyl, trifluoromethyl, carboxyl, phenyl, ethoxy, cyano, ethylthio, amino or hydroxyl radical;
R2 is a hydrogen atom; and
R3 is a hydrogen atom or a methyl, -aminoethyl, ethyl, isopropyl, phenyl, β-hydroxyethyl, methylthio or ethoxy radical.
19. A composition according to claim 17, wherein said pyrazolotetrazoles of formula (Ic) are chosen from those compounds in which:
R1 is a hydrogen atom or a methyl, trifluoromethyl, carboxyl, phenyl, ethoxy or cyano radical; and
R2 is a hydrogen atom.
20. A composition according to claim 17, wherein said pyrazolo[1,5-a]imidazoles of formula (Id) are chosen from those compounds in which:
R1 is a hydrogen atom or a methyl, trifluoromethyl, carboxyl, phenyl, ethoxy, cyano, amino, ethylthio or hydroxyl radical;
R2 is a hydrogen atom; and
R3 and R4 are respectively a hydrogen atom and a hydrogen atom, a hydrogen atom and a methyl radical, a methyl radical and a hydrogen atom, a hydrogen atom and a phenyl radical, or a hydroxyl radical and a hydrogen atom; or R3 and R4 jointly form a phenyl ring.
21. A composition according to claim 17, wherein said pyrazolo[5,1-e]pyrazoles of formula (Ie) are chosen from those compounds in which:
R1 is a hydrogen atom or a methyl, trifluoromethyl, carboxyl, phenyl, ethoxy or cyano radical;
R2 is a hydrogen atom; and
R3 and R4 respectively are a hydrogen atom and a methyl radical, a methyl radical and a hydrogen atom, a methyl radical and a methyl radical, a hydrogen atom and a phenyl radical, or a hydrogen atom and an amino radical.
22. A composition according to claim 17, wherein said pyrazolo[5,1-e]-1,2,3-triazoles of formula (If) are chosen from those compounds in which:
R1 is a hydrogen atom or a methyl, trifluoromethyl, carboxyl, phenyl, ethoxy or cyano radical;
R2 is a hydrogen atom; and
R3 is a hydrogen atom or a methyl radical.
23. A composition according to claim 1, wherein said at least one compound of formula (I) is chosen from:
-7-amino-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-phenylpyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
7-amino-6-phenyl-2-ethylpyrazolo[1,5-b]-124-triazole;
-7-amino-6-phenyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
7-amino-6-ethylthio-2-phenylpyrazolo[1,5-b]-124-triazole;
-7-amino-6-ethoxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-isopropylpyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-(2′-aminoethy)pyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3,6-dimethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
7-amino-6-methyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-isopropylpyrazolo[3,2-c]-1-1,2,4-triazole;
-7-amino-6-ethylthio-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-trifluoromethyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-(trifluoromethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methylpyrazolo[5,1-e]tetrazole;
-7-amino-6-phenylpyrazolo[5,1-e]tetrazole;
-7-amino-6-carboxypyrazolo[5,1-e]tetrazole;
-7-amino-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-2-phenylpyrazolo[1,5-a]imidazole;
-7-aminopyrazolo[1,5-a]benzimidazole;
-7-amino-6-methylpyrazolo[1,5-a]imidazole;
-7-amino-2,6-dimethylpyrazolo[5-a]imidazole;
-7-amino-6-methyl-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-methylpyrazolo[1,5-a]benzimidazole;
-7-amino-6-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-phenyl-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-2,6-diphenylpyrazolo[1,5-a]imidazole;
-7-amino-6-phenylpyrazolo[1,2-a]benzimidazole;
-7-amino-6-carboxypyrazolo[1,5-a]imidazole;
-7-amino-6-carboxy-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-carboxy-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-carboxypyrazolo[1,5-a]benzimidazole;
-7-amino-6-ethoxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxypyrazolo[1,5-a]benzimidazole;
-7-amino-6-(trifluoromethyl)pyrazolo[1,5-a]benzimidazole;
-7-amino-6-aminopyrazolo[1,5-a]imidazole; -7-amino-6-amino-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-amino-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-aminopyrazolo[1,5-a]benzimidazole;
-7-amino-6-(ethylthio)pyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-methyl-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-phenyl-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-hydroxypyrazolo[1,5-a]imidazole;
-6,7-diamino-2-hydroxypyrazolo[1,5-a]imidazole;
-5,8-diamino-4-methylpyrazolo[5,1-e]pyrazole;
-5,7,8-triamino-4-methylpyrazolo[5,1-e]pyrazole;
-6-amino-5-methylpyrazolo[5,1-e]-1,2,3-triazole;
-6-amino-5-phenylpyrazolo[5,1-e]-1,2,3-triazole;
and the acid addition salts thereof.
24. A composition according to claim 17, wherein said pyrazolo[1,5-b]-1,2,4-triazoles of formula (Ia) are chosen from:
-7-amino-2-methylpyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-isopropylpyrazolo[,5-b]-1,2,4-triazole;
-7-amino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-methyl pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-ethylpyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-phenylpyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-6-methyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole; -7-amino-6-methyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-(2′-hydroxyethyl)pyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-(2′-hydroxyethyl)pyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-(2′-hydroxyethyl)pyrazolo[1,2-b]-1,2,4-triazole;
and the acid addition salts thereof.
25. A composition according to claim 17, wherein said pyrazolo[3,2-c]-1,2,4-triazoles of formula (Ib) are chosen from:
-7-amino-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3,6-dimethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-(2′-aminoethyl)pyrazolo[3, 2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-trifluoromethyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-(trifluoromethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
and the acid addition salts thereof.
26. A composition according to claim 17, wherein said pyrazolotetrazoles of formula (Ic) are chosen from:
-7-amino-6-methylpyrazolo[5,1-e]tetrazole;
-7-amino-6-phenylpyrazolo[5,1-e]tetrazole;
-7-amino-6-carboxypyrazolo[5,1-e]tetrazole;
and the acid addition salts thereof.
27. A composition according to claim 17, wherein said pyrazolo[1,5-a]imidazoles of formula (Id) are chosen from:
-7-amino-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-2-phenylpyrazolo[1,5-a]imidazole;
-7-aminopyrazolo[1,5-a]benzimidazole;
-7-amino-6-methylpyrazolo[1,5-a]imidazole;
-7-amino-2,6-dimethylpyrazolo[1,5-a]imidazole;
-7-amino-6-methyl-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-methylpyrazolo[1,5-a]benzimidazole;
-7-amino-6-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-phenyl-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-2,6-diphenylpyrazolo[1,5-a]imidazole;
-7-amino-6-phenylpyrazolo[1,5-a]benzimidazole;
-7-amino-6-carboxypyrazolo[1,5-a]imidazole;
-7-amino-6-carboxy-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-carboxy-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-carboxypyrazolo[1,5-a]benzimidazole;
-7-amino-6-ethoxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxypyrazolo[1,5-a]benzimidazole;
-7-amino-6-(trifluoromethyl)pyrazolo[1,2-a]benzimidazole;
-7-amino-6-aminopyrazolo[1,5-a]imidazole;
-7-amino-6-amino-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-amino-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-aminopyrazolo[1,2-a]benzimidazole;
-7-amino-6-(ethylthio)pyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-methyl-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-phenyl-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-hydroxypyrazolo[1,5-a]imidazole;
-6,7-diamino-2-hydroxypyrazolo[1,5-a]imidazole;
and the acid addition salts thereof.
28. A composition according to claim 17, wherein said pyrazolo[5,1-e]pyrazoles of formula (Ie) are chosen from:
-5,8-diamino-4-methylpyrazolo[5,1-e]pyrazole;
-5,7,8-triamino-4-methylpyrazolo[5,1-e]pyrazole;
and the acid addition salts thereof.
29. A composition according to claim 17, wherein said pyrazolo[5,1-e]-1,2,3-triazoles of formula (If) are chosen from:
-6-amino-5-methylpyrazolo[5,1-e]-1,2,3-triazole;
-6-amino-5-phenylpyrazolo[5,1-e]-1,2,3-triazole;
and the acid addition salts thereof.
30. A composition according to claim 1, wherein said at least one compound of formula (I) is present in an amount ranging from 0.0005 to 12% by weight relative to the total weight of said composition.
31. A composition according to claim 30, wherein said at least one compound of formula (I) is present in an amount ranging from 0.005 to 6% by weight relative to the total weight of said composition.
32. A composition according to claim 1, wherein said medium suitable for dyeing comprises water, a water/alcohol mixture or a mixture of water and of at least one organic solvent.
33. A composition according to claim 32, wherein said at least one organic solvent is a C1-C4 lower alkanol, a glycerol, a glycol, a glycol ether, an aromatic alcohol, or a mixture thereof.
34. A composition according to claim 32, wherein said at least one organic solvent represents from 1 to 40% by weight relative to the total weight of said composition.
35. A composition according to claim 1, wherein said composition has a pH ranging from 3 to 12.
36. A composition according to claim 35, wherein said composition has a pH ranging from 5 to 11.
37. A composition according to claim 1, wherein said composition further contains at least one coupler.
38. A composition according to claim 37, wherein said at least one coupler is chosen from an aromatic diamine, a meta-phenylenediamine, a meta-aminophenol, a meta-diphenol and a heterocyclic coupler.
39. A composition according to claim 38, wherein said at least one coupler is chosen from 2-methyl-5-aminophenol, 5-N-(β-hydroxyethyl)amino-2-methylphenol, 3-aminophenol, 1,3-dihydroxybenzene, 1,3-dihydroxy-2-methylbenzene, 4-chloro-1,3-dihydroxy-benzene, 2,4-diamino-1-(β-hydroxyethyloxy)benzene, 2-amino-4-(β-hydroxyethyl)amino-1-methoxybenzene, 1,3-diaminobenzene, 1,3-bis(2,4-diaminophenoxy)-propane, sesamol, a-naphthol, 6-hydroxyindole, 4-hydroxyindole, 4-hydroxy-N-methylindole, 6-hydroxyindoline, 2,6-dihydroxy-4-methylpyridine, 1H-3-methylpyrazol-5-one, 1-phenyl-3-methylpyrazol-5-one, 2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole, 2,6-dimethyl[3,2-c]-1,2,4-triazole, 6-methylpyrazolo-[1,5-a]benzimidazole, and the acid addition salts thereof.
40. A composition according to claim 37, wherein said at least one coupler is present in an amount ranging from 0.0001 to 10% by weight relative to the total weight of said composition.
41. A composition according to claim 40, wherein said at least one coupler is present in an amount ranging from 0.005 to 5% by weight relative to the total weight of said composition.
42. A composition according to claim 1, wherein said composition further comprises at least one additional oxidation base.
43. A composition according to claim 42, wherein said at least one additional oxidation base is chosen from a para-phenylenediamine, a bisphenylalkylenediamine, a para-aminophenol, an ortho-aminophenol and a heterocyclic base other than said pyrazoloazole compounds of formula (I).
44. A composition according to claim 42, wherein said at least one additional oxidation base is present in an amount ranging from 0.0005 to 12% by weight relative to the total weight of said composition.
45. A composition according to claim 1, wherein said at least one acid addition salt is a hydrochloride, a hydrobromide, a sulphate, a citrate, a succinate, a tartrate, a tosylate, a benzenesulphonate, a lactate or an acetate.
46. A composition according to claim 1, wherein said composition additionally contains at least one direct dye.
47. A method for dyeing keratinous fibers comprising contacting said fibers with at least one oxidation dye composition according to claim 1, in the presence of air or an oxidizing agent, for a time sufficient to achieve color development.
48. The method according to claim 47, wherein said keratinous fibers are human keratinous fibers.
49. The method according to claim 48, wherein said human keratinous fibers are hair.
50. A method according to claim 47, wherein said color development is achieved without an oxidizing agent, but with contact only with atmospheric oxygen.
51. The method according to claim 47, wherein said dye composition is mixed at the time of use with an oxidizing composition comprising, in a medium suitable for dyeing, at least one oxidizing agent present in an amount sufficient for color development.
52. The method according to claim 47, wherein said dye composition additionally contains at least one oxidation catalyst.
53. The method according to claim 52, wherein said at least one oxidation catalyst is a metal salt.
54. The method according to claim 53, wherein said metal salt is manganese, cobalt, copper, iron, silver or zinc.
55. The method according to claim 53, wherein said metal salt is manganese diacetate tetrahydrate, manganese dichloride, manganese triacetate or a hydrate thereof, manganese trichloride, zinc dichloride, zinc diacetate dihydrate, zinc carbonate, zinc dinitrate, zinc sulphate, iron dichloride, iron sulphate, iron diacetate, cobalt diacetate tetrahydrate, cobalt carbonate, cobalt dichloride, cobalt sulphate heptahydrate, cupric chloride or ammoniacal silver nitrate.
56. The method according to claim 53, wherein said metal salt is present in an amount ranging from 0.001 to 4% by weight relative to the total weight of said dye composition.
57. The method according to claim 56, wherein said metal salt is present in an amount ranging from 0.005 to 2% by weight relative to the total weight of said dye composition.
58. The method according to claim 51, wherein said at least one oxidizing agent is hydrogen peroxide, urea hydrogen peroxide, an alkali metal bromate, a persalt, or an enzyme.
59. The method according to claim 58, wherein said persalt is a perborate or a persulphate.
60. The method according to claim 58, wherein said enzyme is a peroxidase or an oxidoreductase with 2 unpaired electrons.
61. The met hod according to claim 47, wherein said color is developed at acidic, neutral, or alkaline pH with an oxidizing agent which is added to said oxidation dyeing composition at the time of application or which is present in an oxidizing composition that is applied:
(i) separately from the dye composition at the same time that said dye composition is applied to said fibers, or
(ii) sequentially with the dye composition.
62. The method according to claim 47, wherein said time ranges from 3 to 50 minutes.
63. The method according to claim 62, wherein said time ranges from 5 to 30 minutes.
64. The method according to claim 51, wherein said oxidizing composition has a pH ranging from 3 to 12.
65. The method according to claim 64, wherein said oxidizing composition has a pH ranging from 5 to 11.
66. The composition according to claim 1, said composition being in the form of a liquid, a cream, a gel or any other form suitable for dyeing keratinous fibers.
67. A multi-compartment dyeing device or kit for dyeing keratin fibers, comprising at least two compartments,
a first compartment of which contains a dyeing composition according to claim 1 and
a second compartment of which contains an oxidizing composition.
68. A compound of formula (I′) chosen from the compounds of the following formulae (I′a) to (I′f):
Figure US20020007520A1-20020124-C00021
in which R′1, R′2, R′3 and R′4 have the same meanings as those indicated in claim 1 for R1, R2, R3 and R4 of the formula (I); it being understood that:
in the compounds of formula (I′b):
i) when R′1 represents a methyl radical and when R′2 represents a hydrogen atom, then the R′3 radical is other than a methyl radical or than a (CH2)3—SO2—(CH2)15—CH3 or CH(CH3)—CH2—SO2—(CH2)11—CH3 radical;
ii) when R′, represents a tert-butyl radical and when R′2 represents a hydrogen atom, then R′3 is other than a (CH2)3—SO2—(CH2)11—CH3 radical;
in the compounds of formula (I'd):
when R′3 and R′4 together form a benzene ring and when R′2 represents a hydrogen atom, then R′1 is other than a methyl, —CONH2 or carboxyl radical;
when R′3 and R′4 together form a benzene ring substituted by a sulphonyl radical in the 4 position and when R′2 represents a hydrogen atom, then R′1 is other than a phenyl radical, than a —(CH2)16—CH3 radical or than a —COOH radical;
when R′3 and R′4 together form a benzene ring substituted by a carboxyl radical in the 4 position and when R′2 represents a hydrogen atom, then R′1 is other than a carboxyl radical.
69. A compound of formula (I′) according to claim 68, wherein said compound is:
-7-amino-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-ethylpyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-methyl pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-ethylpyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
7-amino-6-methyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-(2′-aminoethyl)pyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
6,7-diamino-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-(2′-aminoethyl)pyrazolo[1,2-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
7-amino-6-methyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3,6-dimethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-(2′-hydroxyethyl)pyrazolo[3,2-b]-1,2,4-triazole;
-7-amino-6-methyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-trifluoromethyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-(trifluoromethyl )pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-methylpyrazolo[3,2-c]-1,2,4triazole;
-6,7-diamino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methylpyrazolo[5,1-e]tetrazole; -7-amino-6-phenylpyrazolo[5,1-e]tetrazole;
-7-amino-6-carboxypyrazolo[5,1-e]tetrazole;
-7-aminopyrazolo[1,5-a]imidazole;
-7-amino-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-2-phenylpyrazolo[1,5-a]imidazole;
-7-aminopyrazolo[1,5-a]benzimidazole;
-7-amino-6-methylpyrazolo[1,5-a]imidazole;
-7-amino-2,6-dimethylpyrazolo[1,5-a]imidazole;
-7-amino-6-methyl-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-phenyl-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-2,6-diphenylpyrazolo[1,5-a]imidazole;
-7-amino-6-phenylpyrazolo[1,5-a]benzimidazole;
-7-amino-6-carboxypyrazolo[1,5-a]imidazole;
-7-amino-6-carboxy-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-carboxy-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxypyrazolo[1,5-a]benzimidazole;
-7-amino-6-(trifluoromethyl)pyrazolo[1,5-a]benzimidazole;
-7-amino-6-aminopyrazolo[1,5-a]imidazole;
-7-amino-6-amino-2-methylpyrazolo[5-a]imidazole;
-7-amino-6-amino-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-aminopyrazolo[1,5-a]benzimidazole;
-7-amino-6-(ethylthio)pyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-phenylpyrazolo[1,2-a]imidazole;
-7-amino-6-methyl-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-phenyl-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-hydroxypyrazolo[1,5-a]imidazole;
-6,7-diamino-2-hydroxypyrazolo[1,2-a]imidazole;
-5,8-diamino-4-methylpyrazolo[5,1-e]pyrazole;
-5,7,8-triamino-4-methylpyrazolo[5,1-e]pyrazole;
-6-amino-5-methylpyrazolo[5,1-e]-1,2,3-triazole;
-6-amino-5-phenylpyrazolo[5,1-e]-1,2,3-triazole;
or an acid addition salt thereof.
70. A compound of formula (I′a) according to claim 68, wherein said compound is:
-7-amino-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
7-amino-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole
-7-amino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
7-amino-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-isopropylpyrazolo[1,2-b]-1,2,4-triazole;
-6,7-diamino-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-methylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-ethylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-isopropylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-phenylpyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2, 4-triazole;
-7-amino-6-carboxy-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-methyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethylthio-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-carboxy-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-phenyl-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-6,7-diamino-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-(2′-aminoethyl)pyrazolo[1,5-b]-1,2,4-triazole;
-7-amino-6-ethoxy-2-(2′-hydroxyethyl)pyrazolo[1,5-b]-1,2,4-triazole;
or an acid addition salt thereof.
71. A compound of formula (I′b) according to claim 68, wherein said compound is:
-7-amino-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-3,6-dimethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-methyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-phenyl-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
7-amino-6-phenyl-3-(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethylthio-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-trifluoromethyl-3(methylthio)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-(trifluoromethyl) pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-carboxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-isopropylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-methylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-ethylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-isopropylpyrazolo[3,2-]-1,2,4-triazole;
-7-amino-6-ethoxy-3-phenylpyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-7-amino-6-ethoxy-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-(2′-aminoethyl)pyrazolo[3,2-c]-1,2,4-triazole;
-6,7-diamino-3-(2′-hydroxyethyl)pyrazolo[3,2-c]-1,2,4-triazole;
or an acid addition salt thereof.
72. A compound of formula (I′c) according to claim 68, wherein said compound is:
-7-amino-6-methylpyrazolo[5,1-e]tetrazole;
-7-amino-6-phenylpyrazolo[5,1-e]tetrazole;
-7-amino-6-carboxypyrazolo[5,1-e]tetrazole;
or an acid addition salt thereof.
73. A compound of formula (I′d) according to claim 68, wherein said compound is:
-7-aminopyrazolo[1,5-a]imidazole;
-7-amino-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-2-phenylpyrazolo[1,5-a]imidazole;
-7-aminopyrazolo[1,5-a]benzimidazole;
-7-amino-6-methylpyrazolo[,5-a]imidazole;
-7-amino-2,6-dimethylpyrazolo[1,5-a]imidazole;
-7-amino-6-methyl-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-phenyl-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-2,6-diphenylpyrazolo[1,5-a]imidazole;
-7-amino-6-phenylpyrazolo[1,5-a]benzimidazole;
-7-amino-6-carboxypyrazolo[1,5-a]imidazole;
-7-amino-6-carboxy-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-carboxy-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxypyrazolo[1,5-a]benzimidazole;
-7-amino-6-(trifluoromethyl)pyrazolo[1,5-a]benzimidazole;
-7-amino-6-aminopyrazolo[1,5-a]imidazole;
-7-amino-6-amino-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-amino-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-aminopyrazolo[1,5-a]benzimidazole;
-7-amino-6-(ethylthio)pyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-methylpyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-phenylpyrazolo[1,5-a]imidazole;
-7-amino-6-methyl-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-phenyl-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethoxy-2-hydroxypyrazolo[1,5-a]imidazole;
-7-amino-6-ethylthio-2-hydroxypyrazolo[1,5-a]imidazole;
-6,7-diamino-2-hydroxypyrazolo[1,5-a]imidazole;
or an acid addition salt thereof.
74. A compound of formula (I′e) according to claim 68, wherein said compound is:
-5,8-diamino-4-methylpyrazolo[5,1-e]pyrazole;
-5,7,8-triamino-4-methylpyrazolo[5,1-e]pyrazole;
or an acid addition salt thereof.
75. A compound of formula (I′f) according to claim 68, wherein said compound is:
6-amino-5-methylpyrazolo[5,1-e]-2,3-triazole;
-6-amino-5-phenylpyrazolo[5,1-e]-1,2,3-triazole;
or an acid addition salt thereof.
US09/212,578 1997-12-16 1998-12-16 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles Expired - Fee Related US6379397B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/091,492 US6855827B2 (en) 1997-12-16 2002-03-07 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715947A FR2772379B1 (en) 1997-12-16 1997-12-16 DYE COMPOSITIONS OF KERATINIC FIBERS CONTAINING PYRAZOLO-AZOLES; THEIR USE FOR DYING AS AN OXIDIZING BASE, DYING PROCESS; NEW PYRAZOLO-AZOLES
FR9715947 1997-12-16

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/091,492 Division US6855827B2 (en) 1997-12-16 2002-03-07 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles

Publications (2)

Publication Number Publication Date
US20020007520A1 true US20020007520A1 (en) 2002-01-24
US6379397B2 US6379397B2 (en) 2002-04-30

Family

ID=9514677

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/212,578 Expired - Fee Related US6379397B2 (en) 1997-12-16 1998-12-16 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles
US10/091,492 Expired - Fee Related US6855827B2 (en) 1997-12-16 2002-03-07 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/091,492 Expired - Fee Related US6855827B2 (en) 1997-12-16 2002-03-07 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles

Country Status (8)

Country Link
US (2) US6379397B2 (en)
EP (1) EP0923929B1 (en)
JP (1) JP3135536B2 (en)
AT (1) ATE266378T1 (en)
CA (1) CA2255206A1 (en)
DE (1) DE69823785T2 (en)
ES (1) ES2221702T3 (en)
FR (1) FR2772379B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040088801A1 (en) * 2001-02-14 2004-05-13 Laurent Vidal Novel pyrazolo-triazoles and use of said compounds for dyeing keratinous fibres
US20060053568A1 (en) * 2004-09-08 2006-03-16 Aziz Fadli Novel heteroaromatic binuclear black direct dyes
EP1859782A1 (en) * 2006-05-24 2007-11-28 Henkel Kommanditgesellschaft auf Aktien Composition for coloring and/or lightening human hair comprising tetrazoles
WO2009140451A1 (en) * 2008-05-16 2009-11-19 The Procter & Gamble Company Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140033A (en) * 1998-12-22 2000-10-31 Eastman Kodak Company Photographic element
DE60127521T2 (en) 2000-12-28 2007-12-06 Kao Corp. Hair bleaching and hair dye
EP1275367B1 (en) * 2001-07-09 2006-11-29 Kao Corporation Hair coloring composition comprising pyrazoloazole compounds
DE10112436B9 (en) * 2001-03-15 2005-01-27 Kpss-Kao Professional Salon Services Gmbh Hair dye containing a pyrazolo [5,1c] -1,2,4-triazole derivative
EP1240892B1 (en) * 2001-03-15 2007-05-09 Kao Corporation Hair colouring method and composition comprising a ring-fused heterocycle direct dyestuff
US6783558B2 (en) 2001-03-15 2004-08-31 Kao Corporation Hair coloring method and composition
CN1951939A (en) 2001-05-24 2007-04-25 伊莱利利公司 Novel pyrrole derivatives as pharmaceutical agents
FR2830192B1 (en) 2001-09-28 2004-08-20 Oreal TINCTORIAL COMPOSITION COMPRISING A DIAMINOPYRAZOLE OXIDATION BASE AND A PYRAZOLO-AZOLE COUPLER
FR2845387B1 (en) * 2002-10-04 2005-01-21 Oreal NEW HETEROAROMATIC TRINOCAL BLACK DIRECT COLORANTS
US20050060815A1 (en) * 2002-10-04 2005-03-24 Sylvain Kravtchenko Novel heteroaromatic trinuclear black direct dyes
JP5016181B2 (en) * 2004-01-09 2012-09-05 花王株式会社 Hair dye composition
FR2874821B1 (en) 2004-09-08 2006-10-20 Oreal NOVEL HETEROAROMATIC DI-CORE DIRECT BLACK COLORANTS
WO2009018173A2 (en) * 2007-07-27 2009-02-05 Weatherford/Lamb, Inc. Continuous flow drilling systems and methods
FR2940094B1 (en) * 2008-12-22 2011-02-25 Oreal DETERGENT COSMETIC COMPOSITION COMPRISING FOUR SURFACTANTS, CATIONIC POLYMER AND ZINC SALT
WO2013085554A2 (en) 2011-02-22 2013-06-13 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a naphthalen-1-ol and derivatives thereof
EP2678079B1 (en) 2011-02-22 2017-08-02 Noxell Corporation Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a benzo[1,3]dioxol-5-ylamine and derivatives thereof
CN103379894B (en) 2011-02-22 2016-11-02 宝洁公司 Comprise 1-hexyl/heptyl-4,5-diamino-pyrazole and 1,3-phenylenediamine and the oxidative dye compositions of derivant thereof
WO2013105992A1 (en) 2011-02-22 2013-07-18 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a pyridine and derivatives thereof
WO2013058814A1 (en) 2011-02-22 2013-04-25 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a benzene-1,3-diol and derivatives thereof
EP2677992A1 (en) 2011-02-22 2014-01-01 The Procter and Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a 2-aminophenol and derivatives thereof
CN103491938B (en) 2011-02-22 2017-03-08 宝洁公司 Comprise the oxidative dye compositions of 1 hexyl/heptyl 4,5 diamino-pyrazole and m-aminophenol and its derivant
US9125842B2 (en) * 2011-11-28 2015-09-08 Gw Cosmetics Gmbh Agent and method for coloring keratin fibers
EP2628730B1 (en) 2012-02-16 2017-12-06 Noxell Corporation Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1h-pyrazole salts
EP2628731B1 (en) 2012-02-16 2014-04-23 The Procter and Gamble Company 1-Hexyl-1H-pyrazole-4,5-diamine hemisulfate, and its use in dyeing compositions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1070030B (en) 1958-06-21 1959-11-26
BE619301A (en) 1959-04-06
US3419391A (en) 1965-05-24 1968-12-31 Eastman Kodak Co Silver halide color photography utilizing magenta-dye-forming couplers
GB1334515A (en) 1970-01-15 1973-10-17 Kodak Ltd Pyrazolo-triazoles
JPS5529421B2 (en) 1973-04-13 1980-08-04
GB1458377A (en) 1973-09-13 1976-12-15 Kodak Ltd Pyrazolotriazoles
DE3275761D1 (en) 1981-08-25 1987-04-23 Eastman Kodak Co Photographic elements containing ballasted couplers
JPS5843452A (en) 1981-09-09 1983-03-14 Fuji Photo Film Co Ltd Stabilizing method for silver image
JPS5999437A (en) 1982-10-28 1984-06-08 Fuji Photo Film Co Ltd Color photosensitive silver halide material
JPS59162548A (en) 1983-02-15 1984-09-13 Fuji Photo Film Co Ltd Formation of magenta image
US4621046A (en) * 1983-03-18 1986-11-04 Fuji Photo Film Co., Ltd. Pyrazolo(1,5-B)-1,2,4-triazole derivatives
JPS60172982A (en) 1984-02-16 1985-09-06 Fuji Photo Film Co Ltd Pyrazolo(1,5-b)(1,2,4)triazole derivative
JPS59171956A (en) 1983-03-18 1984-09-28 Fuji Photo Film Co Ltd Formation of color image
JPS6033552A (en) 1983-08-04 1985-02-20 Fuji Photo Film Co Ltd Color image forming method
JPS6043659A (en) 1983-08-19 1985-03-08 Fuji Photo Film Co Ltd Formation of color image
JPS60140241A (en) 1983-12-27 1985-07-25 Fuji Photo Film Co Ltd Silver halide photosensitive material
JPS60190779A (en) 1984-03-12 1985-09-28 Fuji Photo Film Co Ltd Preparation of pyrazolo(1,5-b)(1,2,4)triazole derivative
JPS60197688A (en) * 1984-03-22 1985-10-07 Fuji Photo Film Co Ltd Preparation of pyrazolo(1,5-b)(1,2,4)triazole derivative
JPH068948B2 (en) 1985-01-10 1994-02-02 コニカ株式会社 Silver halide color photographic light-sensitive material
FR2586913B1 (en) 1985-09-10 1990-08-03 Oreal PROCESS FOR FORMING IN SITU A COMPOSITION CONSISTING OF TWO SEPARATELY PACKED PARTS AND DISPENSING ASSEMBLY FOR THE IMPLEMENTATION OF THIS PROCESS
JPS62129851A (en) * 1985-11-30 1987-06-12 Konishiroku Photo Ind Co Ltd Heat developable photosensitive material
JPS6374055A (en) 1986-09-18 1988-04-04 Fuji Photo Film Co Ltd Color photographic sensitive material
EP0285274B1 (en) 1987-03-09 1990-11-07 EASTMAN KODAK COMPANY (a New Jersey corporation) Photographic silver halide materials and process comprising new pyrazoloazole coupler
JPH02188748A (en) 1989-01-18 1990-07-24 Konica Corp Silver halide color photographic sensitive material
DE3942357A1 (en) 1989-12-21 1991-06-27 Boehringer Mannheim Gmbh 3-AMINOPYRAZOLO-HETEROCYCLES, THEIR USES FOR THE DETERMINATION OF HYDROGEN PEROXIDE, HYDROGEN PEROXIDE-FORMING SYSTEMS, PEROXIDASE, PEROXIDATIALLY ACTIVE SUBSTANCES OR OF ELECTRONIC AROMATIC COMPOUNDS, CORRESPONDING PROCEDURES AND COMPOUNDS THEREOF
JP2867173B2 (en) 1990-09-25 1999-03-08 コニカ株式会社 Silver halide color photographic materials
DE4133957A1 (en) * 1991-10-14 1993-04-15 Wella Ag HAIR DYE CONTAINING AMINOPYRAZOLE DERIVATIVES AND NEW PYRAZOLE DERIVATIVES
JPH05222044A (en) * 1991-10-25 1993-08-31 Eastman Kodak Co Preparation of 2equivalent pyrazolotriazol magenta coupler
JPH0627616A (en) 1992-07-09 1994-02-04 Fuji Photo Film Co Ltd Silver halide color photographic sensitive material
US5457210A (en) 1994-04-22 1995-10-10 Eastman Kodak Company Intermediates for the preparation of pyrazoloazole photographic couplers, processes of making and using them
FR2746306B1 (en) * 1996-03-22 1998-04-30 Oreal KERATINIC FIBER DYEING COMPOSITIONS CONTAINING PYRAZOLO-AZOLES; THEIR USE FOR DYEING AS COUPLERS, DYEING METHOD

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040088801A1 (en) * 2001-02-14 2004-05-13 Laurent Vidal Novel pyrazolo-triazoles and use of said compounds for dyeing keratinous fibres
US7192452B2 (en) 2001-02-14 2007-03-20 L'oreal S.A. Pyrazolo-triazoles and use of said compounds for dyeing keratinous fibres
US20060053568A1 (en) * 2004-09-08 2006-03-16 Aziz Fadli Novel heteroaromatic binuclear black direct dyes
US7288124B2 (en) 2004-09-08 2007-10-30 L'oreal S.A. Heteroaromatic binuclear black direct dyes
EP1859782A1 (en) * 2006-05-24 2007-11-28 Henkel Kommanditgesellschaft auf Aktien Composition for coloring and/or lightening human hair comprising tetrazoles
WO2009140451A1 (en) * 2008-05-16 2009-11-19 The Procter & Gamble Company Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof

Also Published As

Publication number Publication date
DE69823785T2 (en) 2005-04-28
US6379397B2 (en) 2002-04-30
JP3135536B2 (en) 2001-02-19
US6855827B2 (en) 2005-02-15
ATE266378T1 (en) 2004-05-15
DE69823785D1 (en) 2004-06-17
CA2255206A1 (en) 1999-06-16
JPH11263790A (en) 1999-09-28
FR2772379B1 (en) 2000-02-11
FR2772379A1 (en) 1999-06-18
EP0923929A1 (en) 1999-06-23
EP0923929B1 (en) 2004-05-12
ES2221702T3 (en) 2005-01-01
US20020152558A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
US6379397B2 (en) Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles
US6248137B1 (en) Compositions for dyeing keratinous fibres, containing 3-aminopyrazolo [1,5-a]pyrimidines, method of dyeing and novel 3-aminopyrazolo [1,5-a]pyrimidines
EP1233743B1 (en) Compositions for dyeing keratinous fibres containing 3-amino pyrazolo-[1,5-a]-pyridines, dyeing method, novel 3-amino pyrazolo-[1,5-a]-pyridines
EP1550656B1 (en) fused 4-5-diamino-n,n-dihydro-pyrazol-3-one derivatives for use in composition for dyeing keratin fibres
EP1792606B1 (en) Composition for dyeing keratinic fibers comprising at least one derivative of 3-amino pyrazolopyridine
KR19990028468A (en) Composition for dyeing keratin fibers containing pyrazolo [1,5-A] pyrimidine derivatives, dyeing method, novel pyrazolo [1,5-A] pyrimidine derivatives and preparation method thereof
US6379395B1 (en) Pyrazolopyrimidinoxo-containing compositions for dyeing keratin fibres; their use in dyeing as couplers; dyeing processes
FR2969151A1 (en) 4-AMINO DERIVATIVES AND THEIR USE FOR COLORING OXIDATION OF KERATIN FIBERS
US6231623B1 (en) Methods of dyeing keratin fibers with compositions containing pyrazolo-azole couplers
US7004979B2 (en) Dyeing composition comprising at least one diaminopyrazole oxidation base and at least one pyrazolo-azole coupling agent
US6139589A (en) Compositions for dyeing keratin fibers containing pyrazolo[3, 4-d]thiazoles as couplers and dyeing methods
US6551360B2 (en) Pyrazoline-3,5-dione-containing compositions for dyeing keratin fibres; their use in dyeing as couplers; dyeing process
EP2093226A1 (en) New aminoindolizines, tinctorial composition comprising an aminoindolizine, methods and uses
US20020032934A1 (en) Composition for oxidation dyeing of keratin fibers, comprising at least one oxidation base chosen from 5-methylpyrazolo(1,5-a)pyrimidine-3,7-diamine and addition salts thereof; dyeing processes using them
ES2221835T3 (en) NEW 2-ACILAMINOFENOLES CATIONICOS, ITS USE BY TITLE OF COPULATOR FOR OXIDATION DYE, COMPOSITIONS THAT INCLUDE THEM, AND DYING PROCEDURES.
US6238440B1 (en) Keratin fibre dye compositions containing pyrrolo-azole compounds, use thereof as couplers, and dyeing method
JP3288387B2 (en) Composition for dyeing keratin fibers containing thiazoloazole S-oxide and / or thiazoloazole S, S-dioxide, its use in dyeing as a coupler and dyeing method
US20010044974A1 (en) Compositions for dyeing keratin fibers, containing cationic indolizine derivatives, and dyeing process
US6063136A (en) Compositions containing pyrrolo-oxazole couplers for dyeing keratin fibers and dyeing methods
EP1551806B1 (en) 6-alkoxy-2,3-diaminopyridine couplers and use of said couplers for the dyeing of keratinous fibres
US6652600B2 (en) Oxidation bases containing a guanidine chain, process for preparing them, their use for the oxidation dyeing of keratin fibers, dye compositions and dyeing processes
FR2820744A1 (en) NOVEL PYRAZOLO-TRIAZOLES AND USE THEREOF FOR THE DYING OF KERATIN FIBERS

Legal Events

Date Code Title Description
AS Assignment

Owner name: L'OREAL S.A., FRANCE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VIDAL, LAURENT;MAUBRU, MIREILLE;REEL/FRAME:009832/0177;SIGNING DATES FROM 19990103 TO 19990104

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20140430